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Abstract 
 
Parkinson’s disease (PD) is a common, disabling, neurodegenerative disease 
characterised by three core motor symptoms: tremor, rigidity and bradykinesia. These 
symptoms arise from degeneration of dopaminergic (DA) cells in the substantia nigra 
(SN) and the subsequent loss of dopaminergic terminals within the striatum, and 
circuits to cortical areas, critical in the control of movement. Other, non-DA systems 
are now known to be involved in the pathogenesis of PD, defective cognitive 
functions and side effects of DA medication treatments. Thus, the use of non-invasive 
in vivo techniques such as magnetic resonance imaging (MRI) has allowed a reliable, 
albeit in-direct method of assessing alterations in the PD brain. It is now widely 
considered that motor control is dependent upon the integrated operation of large-
scale distributed brain networks. Recent methodological advances in MRI techniques 
allow both structural and functional connectivity between critical regions of motor 
control to be investigated and increase our understanding of the impact of PD 
pathology on motor networks and its subsequent effect on symptomatology. In this 
thesis, I present three studies that combine both structural and functional MRI 
techniques to assess the neural PD motor network and to test the general hypothesis 
that loss of effective motor control in PD arises from disrupted connectivity. I 
demonstrate in a sizable cross-sectional study that as disease burden increases, 
effective functioning in key motor areas and functional connectivity between regions 
in both the active and resting state is initially compromised but does show evidence of 
compensatory mechanisms.  In addition, I show that compensatory mechanisms are 
likely to possess a neural reserve property rather than permit a period of normal 
functioning. Next, I present a follow-up study that assessed the active and resting 
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neural motor network longitudinally.  This study clearly shows that functional 
connectivity of the active and resting neural motor network is compromised as the 
disease progresses with evidence suggesting the initiation of compensatory 
mechanisms. Finally, structural properties of key regions related to PD pathology 
(substantia nigra and striatum) have been assessed to elucidate the effect of PD 
progression on diffusion indices and clinical symptoms. This work identifies the 
importance of multi-modal assessment of neural networks in PD to evaluate the effect 
of disease on neural motor control.  
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CHAPTER 1: INTRODUCTION 
1. Epidemiology of Parkinson’s disease 
Parkinson’s disease (PD) affects approximately 120,000 people in the United 
Kingdom (UK), 1 million people in the United States of America (USA) and 4 million 
people worldwide (according to PD UK and PD Foundation of USA). The disease 
target all ethnic groups, although appears to be more prevalent in Caucasians (Van 
Den Eeden et al. 2003) and men are approximately 1.5 times more likely than women 
to develop PD. Disease onset is uncommon before 60 years of age although up to 
10% of cases occur before the age of 40. Overall prevalence rates of PD in the 
population aged 65 and over is 1.8%, rising from 0.6% in 65-69 year olds to 2.6% in 
85-89 year olds (de Rijk et al. 2000). 
 
2. Symptomatology of Parkinson’s disease 
PD is characterised by three cardinal motor symptoms; tremor, rigidity and 
bradykinesia; two of which must be present for a diagnosis of PD to be made. 
Tremor in PD typically presents at rest with a frequency of 4-6 Hz and a characteristic 
‘pill-rolling’ motion in the hands. Tremor initially develops unilaterally although is 
completely absent from symptomatology in approximately 30% of patients. Rigidity 
is an increase in muscle tone and stiffness which leads to resistance of passive 
movements of a joint, whether smooth (lead pipe) or oscillating (cogwheel). 
Bradykinesia is a slowness or absence of movement. This symptom can also affect 
handwriting (micrographia), speech (hypophonia), facial expression (hypomimia).  
In advanced disease, bradykinesia is usually referred to as akinesia and postural 
instability appears (Jankovic 2008). 
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PD patients often suffer from non-motor symptoms, with cognitive, autonomic and 
affective deficits and may be attributed to extra-striatal denervation and possibly to 
non-dopaminergic pathways (Politis et al. 2011).  
The Unified Parkinson’s Disease Rating Scale (UPDRS) is the most common scale 
for the clinical study of PD, which includes both motor (e.g. UPDRS-III) and non-
motor subscales (e.g. UPDRS-IV). 
 
3. Pathogenesis 
3.1 Dopamine and the Substantia Nigra 
PD is primarily due to a reduction of dopamine (DA) concentration in the striatum 
caused by the loss of DA-ergic neurons in the substantia nigra pars compacta (SNc). It 
is known that the ventrolateral portion of the SNc is predominately affected in PD 
compared to normal aging where the dorsal portion is mostly affected by DA atrophy 
(Fearnley & Lees 1991). Motor symptomatologies arise only following the 
denervation of 60% of DA SNc neurons (Gaenslen et al. 2011) and it is estimated at 
this point, DA levels in the PD brain are around 20% of that in a non-PD, healthy 
brain (Tolosa et al. 2009). 
 
3.2 Lewy Bodies 
Lewy bodies (LB) are neuronal intracytoplasmic inclusions of alpha-synuclein, 
ubiquitin and approximately 70 other proteins (Wakabayashi et al. 2007). The 
presence of LB are not exclusive for PD pathological criteria as it is well established 
that other neurodegenerative conditions also present with LB (Popescu & Lippa 
2004). Furthermore, the role of LB as toxic to neurons in neurodegenerative disease is 
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debated due to the lack of LB presence in genetic forms of PD (Poulopoulos et al. 
2012). 
 
3.3  Non-Dopaminergic Pathology 
Emerging evidence suggest that neurotransmitter systems, other than the DA-ergic 
system, play a role in PD. The pre-synaptic serotonergic (5-HT) system has been 
shown to be degenerate in PD in a progressive, non-linear fashion (Politis et al. 2010) 
and loss of 5-HT in brain regions related to motor execution result in an increase of 
action-postural tremor in PD patients (Loane et al. 2013). Non-DA-ergic systems have 
been highly implicated in investigations of the non-motor symptoms of PD. For 
example, 5-HT and adrenergic dysfunction in depression in PD (Politis et al. 2010; 
Frisina et al. 2009) cholinergic dysfunction and glutamatergic dysfunction in 
cognitive impairment in PD (O’Neill & Dix 2007; Mattila et al. 2001). 
 
3.4 The Braak Hypothesis 
The Braak hypothesis (Braak et al. 2003) (Figure 1) of PD consists of six stages 
beginning in the lower medulla and olfactory bulb extending to the SNc at which 
stage the clinical symptoms of PD becomes apparent. Later, pathology reaches the 
allo- and neocortex involving the primary sensory and motor areas. The Braak 
hypothesis offered a revolutionary view of PD pathology and the description of a 
multi-stage pre-symptomatic period resulted in a dramatic increase of investigations 
focused on early detection and preventative methods. 
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Figure 1. Braak stages in the development of Parkinson’s disease. 
 
 
Staging of α-synuclein pathology thought to be associated with the evolution of PD, hypothesis 
suggested by Braak et al., 2003. Pathologic changes initially occur in the olfactory region and lower 
brain stem (stages 1 and 2), extending to the dopamine neurons in SNc, other midbrain regions and 
limbic regions (stages 3 and 4) and finally the association and primary neocortex (stages 5 and 6). 
Clinical motor parkinsonism appears during stages 4 and 5. Figure edited from (Olanow et al. 2009). 
 
4. Pathophysiology 
4.1 The basal ganglia 
The basal ganglia consists of striatum (caudate nucleus and putamen), globus pallidus 
(GP, internal GPi, external GPe), subthalamic nucleus (STN), and SN, SNc and SN 
reticulata (SNr).  These structures form an interconnected system that maintains 
multiple afferent and efferent connections with the cortex (Figure 2). 
There are two main ‘stations’ of the basal ganglia; the input station which consists of 
the putamen receiving signals from the cortex and the output station which comprises 
the SNr and GPi inhibiting signal from the thalamus to the cortex (Obeso et al. 2013). 
There are two major pathways from the output station. The direct pathway has an 
inhibitory effect from the striatum to SNr/GPi, whereas the indirect pathway has a net 
excitatory effect on SNr/GPi through striatum to GPe and STN. 
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Initial concepts of the basal ganglia model focused on control of speed and amplitude 
of movement (Georgopoulos et al. 1983). Although more recent interpretations have 
expanded the model to involve the switching between automatic and controlled 
behaviour (Hikosaka & Isoda 2010) and mediating habitual actions and learning 
(Redgrave et al. 2010). 
 
 
Figure 2. The basal ganglia motor circuit. 
 
  
Diagrammatic representation of the basal ganglia motor circuit in the healthy brain and the PD brain. 
A: Basal ganglia motor circuit model in health; B: Basal ganglia motor circuit model in PD.  GPe – 
globus pallidus externa; GPi – globus pallidus interna; PPN – pedunculopontine nucleus; SNc; SNr; 
STN; VL- ventralis lateralis. Reproduced from (Obeso et al. 2002). 
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4.2 The basal ganglia and PD 
Typically, the direct and indirect circuits described above are balanced so that the 
activity of the basal ganglia output nuclei is well regulated. Facilitation of movement 
is associated with a reduction in the firing rate of basal ganglia nuclei output. 
However, loss of DA causes increased output activity of basal ganglia nuclei (i.e. 
hyperactivity), which in turn leads to the excessive inhibition of the thalamocortical 
and brain stem motor systems (Obeso et al. 2002; Rothwell, 2011). Thus, alterations 
of striatal neuronal excitability shift the balance of the basal ganglia circuitry toward 
the indirect pathway reducing the direct activity. Therefore, motor symptoms are 
expressed as abnormal modulations of the cortico-striatal-pallidal loops, reducing 
cortical activation related to the initiation of movements.  
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5. Functional and structural neuroimaging of Parkinson’s disease 
5.1 Introduction 
The loss of nigro-striatal DA-ergic neurons as the pathophysiological hallmark of PD 
is well established. However, it is not clear how denervation of DA leads to the 
clinical motor symptomatology in PD. The advent of MRI has revolutionised the 
diagnosis and management of many neurological disorders and allowed researchers to 
address in vivo specific functional questions in PD by using Functional magnetic 
resonance imaging (fMRI). 
 
5.2  fMRI studies of motor control in PD 
fMRI provides a non-invasive tool for in vivo brain imaging and has been extensively 
applied to PD research for a wide range of important issues, not least to the 
assessment of brain activity related to motor execution (See Chapter 2 for a detailed 
description of fMRI principles). 
Less than 20 studies using fMRI to comprehensively assess motor control in PD have 
been published to date (Table 1). Comprehensiveness refers to a sample size greater 
than six patients, an experimental contrast of interest i.e. patients vs. controls, an 
active motor task containing a baseline session and studies without DBS or atypical 
medication such as apomorphine due to its known effect on the sensorimotor system.  
These criteria were used based upon the criteria of an earlier meta-analysis (Herz et 
al., 2014). 
In general, a subset of frontal-parietal cortical regions is associated with dysfunctional 
neural activity in PD patients compared to controls: supplementary motor area 
(SMA), primary motor cortex (M1), inferior parietal cortex (IPC) and superior 
parietal lobule (SPL) and putamen.  
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Blood oxygen level dependent (BOLD) signal is the measurement of brain activation 
in fMRI studies and while some studies support findings from positron emission 
tomography (PET) studies i.e. reduction activation in M1 and SMA (Playford et al., 
1992; Jenkins et al. 1992; Buhmann et al. 2003; Haslinger et al. 2001), others are only 
partially consistent, such as reports of increased BOLD signal in the motor cortices 
(Sabatini et al. 2000). Indeed, many factors will contribute to these differences such 
as fMRI task specifics (gross motor, finger tapping, visual or auditory cue), narrow or 
heterogeneous disease population (disease duration, severity, dominant subtype), 
whether patients are scanned ‘ON’ or ‘OFF’ medication just to name a few.  
Due to the pathophysiological hallmark of PD (nigrostriatal denervation), it is 
unsurprising that the posterior putamen has abnormal neural activity in PD patients 
‘OFF’ medication. The posterior putamen receives the majority of nigral DA 
afferents, which are believed to facilitate effective movements, and modulate basal 
ganglia and cortical areas via direct pathways (Gaenslen et al. 2011). UPDRS-III 
scores have been correlated with abnormal putaminal neural activity in fMRI studies 
(Holden et al. 2006; Prodoehl et al. 2010)(Spraker et al. 2010) confirming the role of 
the putamen in motor control. Of particular interest, abnormal putaminal neural 
activity correlating with UPDRS-III can be significantly detected in mild stages of the 
disease i.e. mean UPDRS-III scores of 15 (Holden et al. 2006). It is of great 
importance to be able to detect abnormal activity in the neural motor circuit in pre-
symptomatic PD brains. However, to date, no study has systematically assessed the 
staging of neural dysfunction in PD motor control. 
Only two studies have explicitly attempted to investigate the effect of disease severity 
or progression on neural motor indices with fMRI (Sen et al. 2010; Tessa et al. 2012). 
The only longitudinal assessment was conducted using two types of motor tasks 
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(externally cued hand positions and sequential finger tapping) in five PD patents with 
highly homogenised disease severity (UPDRS-III range 2-7 at baseline and 3-10.5 at 
follow-up) over 2 years (Sen et al. 2010). The authors report an alteration of the 
cerebello-thalamo-cortical (CTC) circuit in PD patients over time but concede that the 
high variability in their results between PD patients and controls was extensive due to 
the small sample size. Tessa and colleagues (Tessa et al. 2012) report SMA 
hypoactivation in 19 de novo PD patients occurring as an effect of disease severity as 
measured by Hoehn and Yahr (H&Y) staging. Unfortunately, this study is limited buy 
a relatively small sample size (n = 19) and exclusion of patients with severe disease. 
To date, no study has used fMRI to comprehensively assess the neural basis of motor 
execution dysfunction as a function of disease course. In order to systematically 
follow the neural decline of effective motor execution, sizable cross 
sectional/longitudinal studies covering multiple disease stages are required.   
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Table 1. fMRI studies of motor control in PD 
Reference Sample size Motor task  Contrast Findings 
(Sabatini et al. 
2000) 
6 PD; 6 C Finger-to-thumb 
and fist clenching 
with external cue 
OFF vs C Decreased BOLD 
in SMA and 
DLPFC. Increased 
BOLD in 
sensorimotor 
cortex, premotor 
area and cingulate 
cortex 
(Haslinger et al. 
2001)  
8 PD; 8 C Joystick-
movement with 
free choice 
OFF vs C Impaired 
activation in SMA 
and increased 
BOLD in M1 and 
lateral PFC  
Buhmann et al., 
2003 
8 PD; 10 C Finger opposition 
task 
OFF vs C Reduced BOLD in 
M1 and SMA 
Wu et al., 2005 12 PD; 12 C Sequential finger 
tapping 
OFF vs C Increased BOLD 
in cerebellum, 
premotor area, 
precuneus, PFC 
(Cerasa et al. 
2006) 
10 PD; 11 C Finger tapping 
with external cue 
OFF vs C BOLD increase in 
cerebellum, 
putamen, SMA, 
thalamus, IFG and 
insula 
(Eckert et al. 
2006) 
9 PD; 9 C Opening and 
closing fist with 
external cue 
OFF vs C BOLD increase in 
pre-SMA 
Holden et al., 
2006 
6 PD; 7 C Motor switching 
task 
OFF vs C Reduced BOLD in 
striatum 
Mallol et al., 
2007 
13 PD; 11 C Finger-to-thumb 
opposition and 
rotation with 
external cue 
OFF vs C Decreased BOLD 
in striatum and 
thalamus 
(Kraft et al. 2009) 12 PD; 12 C Grip-force task 
with external cue 
OFF vs C Increased BOLD 
in putamen 
Spraker et al., 
2010 
14 PD; 14 C Precision grip 
force tasks 
OFF vs C Decreased BOLD 
in striatum, 
thalamus, 
premotor area, 
SMA 
Wu et al., 2010 15 PD; 15 C In-phase 
movements of 
index fingers 
with external cue 
OFF vs C Increased BOLD 
in SMA during 
inphase 
movements but 
decreased BOLD 
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in motor cortices 
during antiphase 
movements  
Prodoehl et al., 
2010 
20 PD; 20 C Precision grip 
force task with 
external cue 
OFF vs C Decreased BOLD 
in striatum, 
thalamus and 
motor cortices 
Tessa et al., 2010 15 PD; 11 C Continuous hand 
tapping with 
external cue 
OFF vs C Increased BOLD 
in cerebellum, 
premotor area, 
precuneus, PFC  
(Pinto et al. 2011) 9 PD; 15 C Joystick-
movements with 
free choice 
OFF vs C Increased BOLD 
in cerebellum, 
precentral gyrus, 
putamen and 
insula 
(Tessa et al. 
2012) 
19 PD; 13 C Continuous 
writing of ‘eight-
figure’ with 
external cue 
OFF vs C Decreased BOLD 
in somatosensory 
cortex and 
cerebellum. 
Increased BOLD 
in SMA and 
frontal areas 
(Tessa et al. 
2013) 
11 PD; 10 C Continuous hand 
tapping with 
external cue 
OFF vs C Decreased BOLD 
in sensorimotor 
area and in creased 
BOLD in parietal 
and frontal areas 
Baglio et al., 
2011 
15 PD; 11 C Index finger 
button presses 
with external cue 
ON vs C Increased BOLD 
in PFC and basal 
ganglia during 
motor inhibition 
Hughes et al., 
2010 
16 PD; 15 C Button presses 
with both 
external cue and 
free choice 
ON vs C Increased BOLD 
in premotor areas 
which decreased 
with age 
PD=Parkinson’s disease; C = Controls; ON = ON medication; OFF = OFF medication. BOLD = 
blood oxygenation level dependent signal; IFG = inferior frontal gyrus; SMA = supplementary motor 
area; M1 = primary motor area; PFC = prefrontal cortex. Publications until the end of 2014. 
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6. Resting state fMRI (rs-fMRI) studies in Parkinson’s disease 
Studying the brain at rest in an attempt to understand its spontaneous neural activity 
without constraints inextricably linked to task-based studies (i.e. subjects ability to 
perform the task, presence of attention-based stimuli) (Biswal et al. 1995; Raichle et 
al. 2001) is a valuable non-invasive tool for in vivo brain imaging. Task-related 
increases in neuronal metabolism are usually small (<5%) when compared to this 
large resting energy consumption. Therefore, differences in task-related changes 
between normal and pathological populations are even smaller. Thus, attempting to 
study disease or diagnose patients based on task-related changes, one is therefore 
focusing on only a very small fraction of the brain's overall activity. Measuring 
ongoing spontaneous activity may provide a window into the neural processing that 
appears to consume the vast majority of the brain's resources and so may prove a 
richer source of disease-related signal changes (Fox & Greicius 2010). 
PD is one neurodegenerative disease, which has benefited from the rs-fMRI research 
(Table 2). The rationale of rs-fMRI focuses on low frequency (<0.1 Hz), spontaneous 
fluctuations in BOLD signal at rest with identification of abnormal patterns or 
disrupted connectivity potentially explaining PD symptoms. As detailed in 
Methodology (Chapter 2), analysis approaches to rs-fMRI in PD is varied, thus 
discrepancies in the current literature exist. However, the value of rs-fMRI in PD is 
reflected in the many studies that have been conducted over the past decade.  
A selection of relatively established resting networks in the healthy brain have been 
identified: default mode network (DMN), sensorimotor network, visual, auditory and 
fronto-parietal networks (Damoiseaux et al. 2006). These networks have been 
identified using independent component analysis (ICA), a technique that separates a 
signal into non-overlapping spatial and time components. It is highly data-driven 
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permitting better removal of noisy components of the signal and has been shown to 
reliably extract DMN as well as many other networks with very high consistency. Rs-
fMRI in neurological disease has shown promise with several studies identifying 
patients with Alzheimer’s disease (AD). For example, graph analysis of rs-fMRI data 
has demonstrated sensitivity of 72% and specificity of 78% in distinguishing AD 
patients from controls (Supekar et al. 2008).  Furthermore, distinguishing different 
dementia types has been demonstrated with 92% accuracy when investigating the 
DMN and salience network in AD patients versus frontotemporal dementia patients 
(Zhou et al. 2010). The clinical relevance of these findings are still to be elucidated, 
although large projects such as the Human Connectome Project are ongoing and 
attempt to understand the association between functional and structural connectivity 
with genetic and behavioural information in several conditions (Essen et al. 2012). 
Assessment of DMN in PD has revealed somewhat inconsistent findings. PD patients 
‘ON’ medication were reported to have no difference in DMN compared to healthy 
controls (Krajcovicova et al. 2012), whereas a similar group imaged by Tessitore et 
al., demonstrated decreased connectivity in the anterior parts of DMN (Tessitore et al. 
2012). The authors also suggest their findings may demonstrate resting neural 
dysfunction prior to cognitive decline in PD. However, no follow-up study has been 
conducted in this group of patients. DMN dysfunction has also been reported in a 
group of medicated PD patients, although areas of dysfunction differ to previous 
studies (Gorges et al. 2013). Further studies of PD patients ‘ON’ medication using 
ICA show increased connectivity in the sensorimotor network compared to controls 
(Esposito et al. 2013) and with graph theory, demonstrate decreased connectivity in 
caudate, orbitofrontal and occipital regions and increased connectivity in 
sensorimotor and parietal areas (Göttlich et al. 2013). The inconsistency of results to 
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date suggest a change of scanning protocol is required and future studies should 
consider imaging PD patients ‘OFF’ medication in an attempt to unify findings due to 
the known effect of levodopa on task-related changes in DMN (Delaveau et al. 2010). 
An investigation of the sensorimotor network in PD with and without medication has 
revealed patients imaged ‘ON’ medication present increased connectivity in the left 
dorso-lateral pre-frontal cortex (DLPFC) and decreased connectivity in the right 
parietal cortex, M1 and left cerebellum (Wu, Wang, et al. 2009). Furthermore, the 
authors report a significant negative correlation between ‘OFF’ UPDRS-III motor 
scores and SMA, putamen, thalamus, premotor area and parietal cortex in the PD 
patients imaged ‘OFF’ medication with authors suggesting that resting putamen 
neural activity may play a part in the motor symptoms of PD. 
The majority of rs-fMRI studies in PD to date have used a seed-based approach and 
are also blighted by discrepant findings. Yu et al., placed seeds in SMA, putamen and 
caudate and reported increased connectivity between SMA and putamen but not SMA 
and caudate in mild-moderate PD patients (Yu et al. 2013), which is partially 
supported and expanded by Helmich et al., who divided the putamen into anterior and 
posterior portions (Helmich et al. 2010). The authors report an increased connectivity 
between anterior putaminal-cortical connections and reduced connectivity between 
posterior putamen and somatosensory and motor cortices, which is supportive of the 
DA loss theory (Kish et al. 1988). Further findings in a study of mild to moderate PD 
patients, imaged while ‘ON’ medication and reports increased striato-cortico 
connectivity which is more prominent in the dorsal striatum (Kwak et al. 2010). 
Baudrexel et al., reported increased connectivity between striatum and motor cortex 
opposed to a decreased connectivity with thalamus, midbrain, pons and cerebellum 
(Baudrexel et al. 2011). A similar study specifically investigating regional resting 
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state connectivity in motor control and execution regions (pre-SMA, M1) report 
increased connectivity between pre-SMA and M1 with a reduction observed between 
pre-SMA and insula, putamen, premotor area and inferior parietal lobule (IPL) (Wu, 
Long, et al. 2011). A study of early stage PD de novo patients revealed reduced 
connectivity between mesolimbic-striatal and cortico-striatal loops (Luo et al. 2014). 
Sharman et al., who used a hierarchical clustering, seed-based approach imaged PD 
patients ‘OFF’ medication (although do state they could not be certain the 12h 
withdrawal period had been adequately implemented by all subjects) report reduced 
connectivity between sensorimotor cortex and thalamus, between GP and thalamus, 
between putamen and GP and between SN, GP, putamen, thalamus (Sharman et al. 
2013). Hacker et al., used putaminal subdivision and caudate seeds in advanced PD 
patients ‘ON’ medication reporting increased striato-cortico connectivity opposed to a 
‘weaker’ connectivity between striatum and thalamus, pons and cerebellum (Hacker 
et al. 2012). Attempts to investigate PD subtype with rs-fMRI are limited although 
small steps have been made. Using independent component analysis (ICA) to 
investigate fronto-parietal and visual networks in PD patients with and without 
freezing of gait symptoms reveal reduced network connectivity in the presence of the 
symptom (Tessitore et al. 2012), while tremor dominant PD patients have been shown 
to have reduced connectivity between dentate nucleus and the posterior cerebellar 
lobe (Luo et al. 2014). Amplitude of low frequency analysis (ALFF) involves spectral 
decomposition of the time series data with a focus on the low frequency domain 
relevant to the hemodynamic response function (i.e. >0.08Hz). PD patients with 
apathy and depressive symptoms have demonstrated that SMA ALFF index and 
subgenual cingulate ALFF index is associated with clinical scores respectively, 
whereas UPDRS-III is predicted by right putamen ALFF index (Skidmore et al., 
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2013). A study investigating medication effect on PD ALFF indices, demonstrated 
that while OFF medications, PD patient have increased indices in the motor and 
frontal regions that is normalized following medication administration (Kwak et al. 
2012). However, a further study using ALFF in PD patients imaged ‘OFF’ medication 
reports a decreased index in SMA, mesial frontal regions, MTG and left cerebellum 
(Skidmore, Yang, Baxter, K. M. von Deneen, et al. 2013). Regional homogeneity 
analysis (ReHo) is is a voxel-based measure of brain activity that evaluates the 
similarity or synchronization between the time series of a given voxel and its nearest 
neighbours. This measure is based on the hypothesis that clusters of voxels rather than 
single voxels manifest intrinsic brain activity. The only study to date using ReHo in 
PD rs-fMRI investigated medication effects and found a reduction of ReHo in 
putamen, thalamus and SMA when ‘OFF’ medication which was normalised 
following administration of medication (Wu, Long, et al. 2009).  
Using Granger connectivity analysis (GCA) is an effective connectivity analysis 
method for inferring directions of neural interactions and information flow directly 
from neuroimaging data, which can estimate the directionality of modulation from 
recorded time series across all nodes of a network without a priori assumptions. 
Using GCA, Wu et al., reported that SNc predicted decreased connectivity with SMA, 
DMN and DLPFC in mild to moderate PD patients whereby SNc predicted an 
increase in the same regions in healthy controls (Wu et al. 2012). Finally, the only 
study to date which has implemented rs-fMRI following surgical intervention, reports 
deep brain stimulation (DBS) results in an increased effective connection of striatal-
cortico and thalamo-cortico pathways whereas all STN and striatal afferents/efferents 
and STN-thalamic connections were decreased in effective connectivity (Kahan et al. 
2014).  
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It is clear from the current literature that rs-fMRI in PD needs to be ‘cleaned-up’. That 
is, a more cohesive analysis pipeline, more regard to medication effects and large 
homogenous patient groups are required to clearly identify the value of rs-fMRI in PD 
and determining its use in differentiating PD from other neurodegenerative disease, 
use as a bio-marker or use as end-points for clinical trials. It appears that prolonged 
use of DA-ergic medication and increased disease severity have an effect on the 
observed rs-fMRI networks, whether it be a natural progression of network 
dysfunction or reorganisation is yet to be elucidated.  
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Table 2. RSN. Main rsfMRI publications in Parkinson’s disease 
Reference Sample 
Size 
Analysis method Group 
characteristics 
Findings 
(Esposito et 
al. 2008) 
20 de 
novo 
PD; 18 
C 
ICA ‘ON’ medication 
PD  
↑ connectivity 
in 
sensorimotor 
area 
(Wu, Wang, et 
al. 2009) 
22 PD; 
22 C 
Graph theory PD patients 
‘ON’/’OFF’ 
medication and 
controls 
’OFF’ PD 
patients ↓ 
connectivity in 
SMA< 
DLPFC, 
putamen and ↑ 
connectivity in 
cerebellum, 
M1, parietal 
cortex. ‘ON’ 
PD patients ↑ 
connectivity in 
left DLPFC 
and ↓ 
connectivity in 
parietal cortex, 
right M1, left 
cerebellum 
(Wu, Long, et 
al. 2009) 
 
22 PD ReHo PD ‘ON’ and ‘OFF’ 
medication  
↓ ReHo in 
putamen, 
thalamus and 
SMA in ‘OFF’ 
PD and 
normalized 
following 
medication 
administration 
(Kwak et al. 
2010) 
24 PD; 
24 C 
ALFF PD ‘ON’ and ‘OFF’ 
medication 
‘OFF 
medication, 
↑ALFF in 
primary and 
secondary 
motor areas 
and frontal 
regions. 
Medication 
administration 
reduced but not 
normalized 
these results.  
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(Helmich et 
al. 2010) 
41 PD; 
36 C 
Seed-based 
(subdivion of 
putamen) 
‘OFF’ mild- 
moderate PD 
patients  vs. controls 
↑ connectivity 
anterior 
putamen and 
cortex. ↓ 
connectivity 
between 
posterior 
putamen and 
somatosenosry 
and motor 
cortices 
(Kwak et al. 
2010) 
25 PD; 
24 C 
Seed-based (six 
striatal seeds) 
‘ON’ mild- 
moderate PD 
patients  vs. controls 
↑ connectivity 
between 
striatum and 
cortex, more 
prominent in 
dorsal 
putamen. 
(Baudrexel et 
al. 2011) 
31 PD; 
44 C 
Seed-based (STN 
and motor cortex) 
‘OFF’ PD vs. 
controls 
↑ connectivity 
between STN 
and motor 
cortex 
(Wu, Long, et 
al. 2011) 
18 PD; 
18 C 
Seed-based (pre-
SMA, M1) 
‘OFF’ PD vs. 
controls 
↑ connectivity 
between pre-
SMA and M1. 
↓ connectivity 
between pre-
SMA and 
insula, 
putamen, 
premotor area 
and IPL 
(Krajcovicova 
et al. 2012)  
18 PD; 
18 C 
ICA, DMN ‘ON’ medication 
PD vs. controls 
No differences 
(Tessitore et 
al. 2012) 
16 PD; 
16 C 
ICA, DMN ‘ON’ medication 
PD vs. controls 
PD ↓ 
connectivity in 
right MTL and 
bilateral IPC 
(Hacker et al. 
2012) 
13 PD; 
19 C 
Seed-based 
(anterior/posterior 
putamen, caudate) 
‘ON’ Advanced PD 
vs. controls 
↓ connectivity 
between 
striatum and 
thalamus, 
midbrain , 
pons, 
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cerebellum and 
↑ connectivity 
with motor 
cortex 
(Wu et al. 
2012) 
 
22 PD; 
22 C 
GCA ‘OFF’ mild- 
moderate PD vs. 
controls 
Decreased 
activity of SNc 
on SMA, 
DMN and 
DLPFC in PD 
patients.   
(Gorges et al. 
2013)  
12 PD; 
13 C 
Seed-based, 
region-region, 
DMN 
‘ON’ medication 
PD vs. controls 
↓between 
medial 
prefrontal 
cortex and 
posterior 
cingulate. ↑ 
connectivity 
between 
bilateral 
hippocampus 
(Göttlich et al. 
2013) 
37 PD; 
20 C 
Graph theory ‘ON’ medication 
PD vs. controls 
↓ connectivity 
in caudate, 
orbitofrontal, 
occipital 
regions and ↑ 
connectivity in 
sensorimotor 
and parietal 
areas  
(Liu et al. 
2013) 
18 PD; 
18 C 
Seed-based 
(cerebello-
thalamo-cortical 
loop: dentate 
nucleus) 
‘OFF’ PD 
tremor/akinetic 
rigid sub groups and 
controls 
↑ connectivity 
between 
dentate and 
cerebellar 
posterior lobe 
in PD vs. 
controls. ↓ 
connectivity in 
same regions 
for the tremor 
subgroup 
(Sharman et 
al. 2013) 
45 PD; 
36 C 
Seed-based, 
hierarchical 
clustering 
‘OFF’ PD (unclear 
if patients actually 
‘OFF’ medication) 
↓ connectivity 
between: 
sensorimotor 
cortex-
thalamus, 
globus 
pallidus-
putamen-
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thalamus, 
substantia 
nigra-globus 
pallidus-
putamen-
thalamus 
(Skidmore, 
Yang, Baxter, 
K. M. von 
Deneen, et al. 
2013) 
22 PD ALFF PD with 
apathy/depression 
UPDRS-III 
predicted by 
ALFF in right 
putamen and 
Apahy score 
predicted by 
ALFF in left 
SMA. 
Depression 
score predicted 
by ALFF in 
subgeneal 
cinglulate 
(Skidmore, 
Yang, Baxter, 
K. von 
Deneen, et al. 
2013) 
14 PD; 
15 C 
ALFF PD ‘OFF’ 
medication 
↓ ALFF in 
SMA, mesial 
frontal regions, 
MFG, left 
cerebellum 
(Luo et al. 
2014) 
52 PD; 
52 C 
Seed-based 
(anterior/posterior 
putamen, caudate) 
Early stage de novo 
PD vs. controls 
↓ connectivity 
in mesolimbic-
striatal and 
cortico-striatal 
loops 
(Kahan et al. 
2014) 
12 PD GCA PD with and 
without DBS 
DBS 
↑effective 
connection of 
cortico-strital 
and thalamo-
cortico 
pathways. ↓of 
all STN/striatal 
afferents and 
efferent and 
STN-thalamic 
connections 
ICA = independent component analysis; ReHo = regional homogeneity; ALFF = amplitude low-
frequency fluctuations; GCA = granger causality analysis; DMN = default mode network; 
PD=Parkinson’s disease; IPC = inferior parietal cortex; IPL = inferior parietal lobule; SMA= 
supplementary motor area; M1= primary motor area; DLPFC = dorsolateral prefrontal cortex; STN 
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= subthalamic nucleus; MTG = middle temporal gyrus; MOG = middle occipital gyrus; DBS = deep 
brain stimulation. Publications until the end of 2014. 
 
7. Diffusion tensor imaging in Parkinson’s disease 
Diffusion tensor imaging quantifies the diffusional displacement of water molecules 
in brain tissue. In white matter, the quantification of diffusion is more complicated 
due to its anisotropic nature and requires a tensor. The advent of DTI provides a new 
image contrast, which enhances the white matter signal and yields quantitative 
measures that characterize the integrity of the white matter tracts. The most 
commonly used indices in PD research are fractional anisotropy (FA) and mean 
diffusivity (MD). FA measures the portion of the diffusion tensor due to anisotropy. 
For highly oriented structures such as white matter, FA approached one, while for 
isotropic diffusion (e.g. CSF) FA is zero. MD represents the overall diffusivity of 
molecules and indicates the overall presence of obstacles to diffusion.  
These quantitative measures represent microstructure of both white and grey matter, 
thus their use in assessing microstructural damage in neurodegenerative disorders are 
potentially extremely useful. DTI analysis typically has three main approaches: ROI 
analysis, voxel-based analysis and tract based spatially statistics (TBSS). All three 
methods have been applied to data in the literature resulting in quite inconsistent 
findings (Table 3).  
Previous studies using DTI in PD have conducted ROI-based analyses with a priori 
hypotheses, most commonly, the SN. In general, these studies have reported 
consistent findings of FA reduction in the SN. One of the earliest studies reports 
included subjects with PD, progressive supranuclear palsy (PSP) and healthy controls 
(Yoshikawa et al. 2004). By using 15 ROIs placed along areas involving nigrostrital 
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and extrapyramidal tracts the authors found a significant reduction of FA in the ROIs 
placed in nigro-striatal tract areas in the PD patients compared to controls. These 
findings were specific to PD patients as the PSP patients demonstrated a reduction of 
FA across all ROIs. The authors concluded their findings were indicative of the DA-
ergic loss observed in PD reflected in white matter microstructural damage. Péran et 
al., reported a reduction of nigral FA and thalamic FA as well as an increase of 
thalamic MD (Péran et al. 2010). Rolheiser et al., (2011) also reported reduced nigral 
FA as well as an increase of radial diffusivity (RD) in the SN of PD patients with 
sensitivity to distinguish patients from controls (Rolheiser et al. 2011). A striking 
confirmation of reduced nigral FA and its possible use as a biomarker was reported in 
a group of early de novo PD patients (Vaillancourt et al. 2009). The authors were able 
to distinguish PD patients from healthy controls with 100% specificity and sensitivity 
from the findings in the caudal part of SN, although, no other study to date has been 
able to replicate this degree of specificity. 
SN FA reduction in PD patients has also been demonstrated in a case-control study 
with FA inversely correlating with disease severity (Chan et al. 2007). No significant 
differences in FA were found in any other basal ganglia structures and an alternative 
measure of diffusion (apparent diffusion coefficient [ADC]) in the SN were found to 
be similar between PD patients and healthy controls. In addition, microstructure 
alterations have been reported in established motor circuit regions: SN, putamen, 
thalamus, M1, premotor and SMA and somatosensory areas with nigral FA 
correlating with disease severity (Zhan et al. 2012). The correlation of SN FA and 
disease severity, thus its potential use as a biomarker, is debated due to differing 
reports. Whereas Chan et al., (2007) and Zhan et al., (2012) find a correlation, other 
studies do not (Vaillancourt et al. 2009; Menke et al. 2010; Du et al. 2011). This has 
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lead to the question whether FA in the SN can be used as a diagnostic marker and has 
been tackled by two recent systematic reviews (Cochrane & Ebmeier 2013; Schwarz 
et al. 2013) with opposing conclusions. Cochrane et al., (2013) considered 43 studies 
of DTI in parkinsonian syndrome, of which nine were studies of SN diffusion indices 
in PD. The authors were optimistic of the use of DTI as a potential biomarker for PD 
as all but one of their included studies reported a reduction of FA in the SN of PD 
patients, seven of which were significant. Conversely, Schwarz et al., (2013) who 
conducted a literature review, meta-analysis and case control study were less 
optimistic of supporting nigral FA as a diagnostic marker. The authors propose 
standardisation of SN anatomical delineation to ascertain if the inclusion of peri-
nigral white matter and effect of iron deposition affects the measurement of nigral 
FA. 
A variety of tensor-derived changes in extra-nigral regions have been reported in 
small selection of studies (Gattellaro et al. 2009; Ibarretxe-bilbao et al. 2009; Zhan et 
al. 2012). FA reductions in corpus callosum genu and superior longitudinal fasciculus 
and MD increase in the same regions plus cingulum have been demonstrated in early 
stage, medicated PD patients (Gattellaro et al. 2009). This was the first study to 
demonstrate superior longitudinal fasciculus is impaired in PD, although it should be 
noted that the findings were not sufficient to discriminate the PD patients from the 
healthy controls. FA reduction in gyrus rectus has been reported (Ibarretxe-bilbao et 
al. 2009) as well as FA reductions and MD increases in motor and frontal cortices 
(Zhan et al. 2012) and track density indices were found to be increased in regions 
associated with the motor circuit (Ziegler et al. 2013). However, other studies have 
failed to find significant differences of extra-nigral FA or ADC in the striatum and 
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thalamus (Chan et al. 2007), or FA and MD in corpus callosum and cingulum 
(Wiltshire et al. 2010). 
Studies using only whole brain diffusivity techniques also have variability in reported 
findings. Kim et al. (2013) employed TBSS and voxel-based analysis (VBA) and 
report no significant differences of FA in PD patients compared with healthy controls. 
Increased MD was reported in striatum, pallidum, thalamus, cingulum and fornix 
(Kim et al. 2013).  Zhan et al., (2012) used VBA to identify a reduction of FA in the 
cerebellum and increased MD in the orbital-frontal cortex and inferior temporal gyrus 
(Zhan et al. 2012).   
DTI offers a promising technique to understand changes in brain microstructure in 
neurodegenerative disease although there are many methodological and theoretical 
considerations prior to collection of data and interpretation of results. 
Methodologically, the scanning protocol should be optimised taking into account the 
subject group under examination. It has been reported that in PD patients that an 
emphasis on the number of diffusion directions leads to a greater sensitivity of FA 
measures, whereas, an emphasis on increasing the number of b values leads to a 
greater sensitivity to MD measures (Rae et al. 2012).  Unfortunately the literature is 
highly varied in terms of the scanner and acquisition protocols used, leading to 
difficulty in interpretation of results and reliable evaluation of which parameters are 
optimal in DTI scanning of PD patients. Furthermore, patient disease stage may 
indirectly influence results. To assess the role of DTI as a potential biomarker or a 
marker for disease progression, more studies involving early stage patients and/or 
patients followed longitudinally (see chapter 5) need to be conducted. Regarding 
analysis, the majority of studies have conducted a priori ROI analysis, which is reliant 
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upon accurate delineation of ROIs and does not account for effects occurring outside 
the ROIs and may be subject to user-bias and partial volume effects.  
The general consensus is that DTI may be a valuable tool as an imaging biomarker for 
PD. However, further studies focusing on premanifest disease, monitoring 
progression and longitudinal studies are required to enable netter assessment of 
preliminary findings. Furthermore, congruency across imaging protocols, use of 
higher field magnets and multi-modal imaging should be considered in future studies 
(Cochrane & Ebmeier 2013) 
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Table 3. Main DTI publications in Parkinson’s disease  
Reference Sample Size Analysis 
method 
Diffusion indices  
Measured/ROIs 
Regions studies 
Findings 
(Yoshikawa et al. 
2004) 
12 PD; 8 C ROI FA/ 
PMC, BG 
↓ FA in SN 
(Chan et al. 2007) 73 PD; 78 C ROI FA and ADC/ 
Caudate, putmaen, 
thalamus, globus 
pallidus, SN 
NS 
(Karagulle Kendi 
et al. 2008) 
12 PD; 13 C VBA FA, MD/ 
Whole brain 
↓ FA in SN  
(Vaillancourt et al. 
2009) 
14 PD; 14 C ROI FA, RD, LD/ 
SN, cerebral peduncle 
↓ FA, LD in 
SN ↑ RD in 
SN 
(Gattellaro et al. 
2009) 
10 PD; 10 C ROI FA, MD/ 
CST, SLF, CI, CC 
genu, splenium 
↓ FA in CC 
genu, SLF 
↑ MD in 
CC genu, 
SLF and 
cingulum  
(Menke et al. 
2010) 
10 PD; 10 C ROI FA/SN NS 
(Ibarretxe-bilbao et 
al. 2009) 
24 PD; 24 C ROI, TBSS FA/ 
POC, gyrus rectus, UF 
↓ FA in 
gyrus rectus 
(Wiltshire et al. 
2010) 
29 PD; 15 C Tract FA, MD/ 
CC, cingulum 
NS 
(Péran et al. 2010) 30 PD; 22 C ROI FA, MD/ 
Thalamus, putamen, 
caudate, pallidum, red 
nucleus, SN 
↓ FA in SN, 
thalamus ↑ 
MD in 
thalamus 
(Rolheiser et al. 
2011) 
1 PD; 14 C ROI FA, RD/ 
SN, AOS 
↓ FA in SN, 
AOS ↑ RD 
in SN 
(Du et al. 2011) 40 PD; 28 C ROI FA/SN NS 
(Zhan et al. 2012) 12 PD; 20 C ROI and VBA FA, MD/ 
Frontal, parietal, SN, 
external capsule, IC, 
thalamus, putamen 
↓ FA in 
frontal, 
parietal, 
SN, external  
and internal 
capsule, 
thalamus 
and 
putamen 
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Abbreviations: AOS = anterior olfactory structures; BG = basal ganglia; CC = corpus callosum; CST 
= corticospinal tract; ITG = inferior temporal gyrus; LD = longitudinal diffusivity; MD = mean 
diffusivity; NS = not significant; OFC = orbital frontal cortex; PMC = premotor cortex; POC = 
primary olfactory cortex; RD = radial diffusivity; ROI = region of interest; SN = substantia nigra; 
TBSS = tract based spatial statistics; tract = tractography; UF = uncinate fasciculus; VBA = voxel 
based analysis. Publications until the end of 2014. 
 
 
 
 
 
 
 
 
 
 
 
 
(Prakash et al. 
2012) 
11 PD; 12 C ROI FA, ADC/ SN ↓ FA in SN, 
asymmetric 
(Skorpil et al. 
2012) 
18 PD; 16 C ROI FA/ 
SN, Olfactory bulb 
↓  FA in SN 
(Kim et al. 2013) 64 PD; 64 C TBSS, VBA FA, MD/ 
Whole brain 
↑ MD in 
caudate, 
putamen, 
pallidum, 
thalamus, 
cingulum 
and fornix 
(Ziegler et al. 
2013) 
29 PD; 27 C TBSS, VBA FA, MD, TDI/ 
Whole brain 
↑ TDI in 
motor, 
cognitive 
and limbic 
networks 
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8. Summary of Aims 
 
To date, neuroimaging studies investigating motor execution in PD commonly report 
a hypoactivation and loss of connectivity between specific motor related regions when 
completing motor tasks in-scanner (e.g. M1, SMA, premotor area) with suggestions 
that this could reflect compensation mechanisms in an attempt to overcome increased 
difficulty for patients to complete motor actions. Furthermore, the increase of rs-fMRI 
studies in recent years has produced general reports of disrupted resting motor 
networks and potential reorganization of cortico-striatal loops. The literature clearly 
indicates that the assessment of both signal amplitude change and connectivity 
alterations need to be considered for a complete understanding of brain function in 
PD. Further to this, structural changes measured with DTI are also vital. Currently, 
the literature is not clear as to how useful DTI may be in providing a MRI biomarker 
in PD or how disease affects diffusion in the PD brain. It is likely that measures such 
as FA and MD are capable of detecting changes over time, but more robust and 
careful studies are required before conclusions can be made. Therefore, despite a 
relatively large number of neuroimaging investigations, the neural (functional or 
structural) course of motor execution decline and/or compensation in PD is still 
unclear. 
In this thesis I have presented the results from three studies investigating the motor 
brain networks in PD from both a functional and structural perspective. The broad 
aims from these three studies are: 
• to assess the activated and resting motor network in a sizable cross-sectional 
study of PD patients spanning four disease burdens in the context of both 
potential dysfunctional and compensatory activations. A subsidiary aim was to 
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investigate if collection of in-scanner behavioural data could assist 
interpretation of neural information.   
• to assess activated and resting motor networks in a group of PD patients over 
time to serve as a confirmatory study of Chapter 3 by using a within-subject, 
longitudinal design. 
• to assess nigro-striatal diffusion indices in PD patients over time to elucidate 
whether these measures can be informative in the investigation of aberrant 
diffusion in key PD related motor regions.  
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CHAPTER 2: SUBJECTS AND METHODOLOGY 
1. Patients 
1.1  Recruitment 
All PD patients included in this thesis were recruited via the TransEuro FP7 EU 
consortium programme. Patients were initially identified from specialist movement 
disorder clinics from one of four centres: Hammersmith Hospital, Imperial College 
Healthcare NHS trust, London; Addenbrookes Hospital, Cambridge University 
Hospitals NHS foundation trust, Cambridge; National Hospital for Neurology and 
Neurosurgery, University College London Hospitals NHS Foundation Trust, London; 
Skåne University Hospital, Lund, Sweden; University Hospital, Lund, Sweden. 
Healthy control recruitment was not included in the TransEuro study. 
 
TransEuro FP7 
The TransEuro programme was set up to conduct a clinical trial of fetal cell 
transplantation in the PD brain.  The results from previous trials have provided a 
proof of principle that cell replacement can work in humans, with some patients 
reporting a huge improvement of motor symptoms with reduced ‘off’ period, motor 
complications and some patients even requiring less or complete withdrawal from 
DA-ergic therapy post-operatively. However, they also revealed troublesome adverse 
effects, the so-called graft induced dyskinesia. The current trial aimed to counter 
previous unknowns which may have contributed to the variable results and conduct 
uni-lateral and bi-lateral grafts in the caudate and putamen of 20 patients. At the time 
of thesis submission, only one subject had successfully undergone graft surgery (May 
2015). 
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1.2  Inclusion and exclusion criteria 
All patients were required to fulfill the following criteria at time of recruitment to be 
eligible. 
Inclusion: 
- PD as defined using Queen's Square Brain Bank criteria. 
- Disease duration ≥ 2 years and ≤ 13 years. 
- Aged ≥ 30 years and ≤ 68 years at the time of grafting. 
- Hoehn & Yahr stage 2.5 or better when 'on'. 
- On standard anti PD medication without significant LIDs (levodopa 
induced dyskinesia) defined as a score of >2 on the abnormal involuntary 
movement scale (AIMS) dyskinesia rating scale, in any body part. 
- Patients must be right handed. 
 
Exclusion: 
-­‐ Atypical or secondary parkinsonism including F-DOPA PET patterns 
consistent with this. 
-­‐ No clinically significant response to Levodopa (as evaluated by the clinician) 
and/or apomorphine challenge. 
 Mini-Mental State Examination (MMSE) score of less than 26. 
- Unable to do normal copying of interlocking pentagons and semantic fluency 
score for naming animals of less than 20 over 90 seconds as these have recently 
been associated with the earlier onset of dementia in PD. 
-­‐ Ongoing major medical or psychiatric disorder including depression and 
psychosis. 
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-­‐ Other concomitant treatment with neuroleptics (inc. Atypical neuroleptics) and 
cholinesterase inhibitors. 
-­‐ Significant drug induced dyskinesia defined as a score of >2 on the AIMS 
(abnormal involuntary movement scale) dyskinesia rating scale, in any body 
part. 
-­‐ Previous neurosurgery, cell therapy or organ transplantation. 
-­‐ Unable to be imaged using MRI. 
-­‐ Any contraindication to immunosuppression therapy. 
-­‐ Patients on anticoagulants 
-­‐ Patients who are left handed 
 
1.3 Clinical evaluation 
As part of the TransEuro programme, all PD patients recruited and included in this 
thesis were clinically evaluated every 6 to 12 months. Evaluations included: 
Neurological examination, total UPDRS (including ON and OFF medication UPDRS-
III scores), AIMS and MMSE. 
 
2. Magnetic resonance imaging (MRI) 
2.1  Principles 
MRI is a non-invasive and safe technique to generate internal images of the body to 
be used in either clinical or research settings. Images are generated using a strong 
magnetic field based upon principles of nuclear magnetic resonance (NMR). 
Changing magnetic gradients and oscillating electromagnetic fields, known as pulse 
sequences are used to detect different tissue properties leading to the generation of 
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images differentiating between low and high proton density, grey and white matter or 
fluid and tissue.  
 
2.2  Nuclear Magnetic Resonance 
Protons and neutrons within atoms spin on their axis producing an angular 
momentum. If an atom has an uneven number of protons and neutrons, the vector will 
be different from zero.  Due to protons mass property, spin phenomenon and positive 
charge, a small magnetic field is produced and named a magnetic moment. This 
magnetic moment is orientated similarly to the angular momentum thus producing a 
ratio constant, gyromagnetic ratio (γ), which is specific to each magnetically active 
nucleus.  Due to hydrogen possessing a significant magnetic moment and existing in a 
high abundance in the human body, MRI scanners can be configured to detect it.  The 
hydrogen nucleus atom contains a single proton, which behaves as a tiny bar magnet. 
As such, the spin properties align parallel or anti-parallel to the direction of the 
magnetic field when placed inside a large magnetic field (b0). When protons are 
aligned in a parallel state, they are said to be in a low energy state compared to an 
anti-parallel alignment and in a high energy state. Thus the higher the b0, the more 
protons that are in a low energy state. It is this ratio that produces a net magnetisation 
vector (M) proportional to the b0. Additionally, protons precess at a particular 
frequency that is equal to the strength of b0 multiplied by the gyromagnetic ratio: the 
Lamour frequency (ω0). 
Different tissues possess differing amounts of hydrogen, thus their behaviour in a 
magnetic field will vary. For example, water has one of the strongest magnetic fields 
due to its high abundance of hydrogen compared to brain tissue. The use of MRI to 
differentiate tissue types involves orienting M away from the b0 axis (z axis) toward a 
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perpendicular plane (transverse xy) and its constants associated with its reorientation 
to the z axis is what is measured by the scanner. To do this, a radio frequency (RF) 
wave oscillating at the lamour frequency is administered resulting in the spins 
beginning to precess in phase: a phenomenon known as resonance. On continuation of 
the pulse, spins in the low energy state will absorb the RF field energy and become 
‘excited’ into the high energy state, causing these proton to ‘flip’ M away from the z 
axis. Spins that had moved to the high energy state will now return to the low energy 
state causing a reorientation of M to the z axis. This phenomenon is known as 
relaxation and is described by two constants: T1 and T2 (Figure 3). T1 longitudinal 
relaxation time is the decay constant for recovery of z to M. T2 is the decay constant 
for the xy component of M. T2* is a related constant of T2 which accounts for the 
inhomegnieties in b0 and neighbouring spin-spin interaction. Due its rapid processing 
time, this constant is very useful in functional MRI. 
 
2.3  Image formation 
Identification of the origin of MR signal (spatial information) is acquired through the 
use of gradients. Gradients are spatially linear variations in the static field strength 
and can be applied in orthogonal directions and the speed of precessing determines 
detection of higher or lower MR signal. Gradient coils inside the scanner, generate a 
magnetic field increasing in strength across a single direction, thus multiple coils are 
applied. Therefore, image reconstruction can occur in three dimensions via frequency 
measurements in different positions in space. 
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Figure 3. T1-weighted and T2-weighted image examples. 
  
 
 
 
 
 
 
 
 
 
 
 
Images of a single subject. A: T1-weighted image which shows the grey matter bright and the cerebral 
spinal fluid (CSF) darker and hypointense lesion. B: T2-weighted image highlighting the CSF  
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3. Functional MRI 
3.1  The BOLD signal 
Blood-oxygen-level-dependent (BOLD) signal is the MRI contrast of blood 
deoxyhemoglobin. Neurons do not store internal reserves of glucose and oxygen, 
which are essential to their proper function. Increases in neuronal activity, typically in 
response to a demand for information processing, require more glucose and oxygen to 
be rapidly delivered via the blood stream. The processes of this heamodynamic 
response (explained below) can be exploited and as such provide a localizer marker of 
activity for fMRI.  
The haemodynamic response corresponds to an increase of cerebral blood flow 
(CBF), blood volume (BV) and blood oxygenation. During neuronal firing, 
oxygenation increases by approximately 5%, and CBF to the local area by 20-40%. 
Increases of CBF can take up to 6 s, therefore the time course of this change is a ratio 
of oxyhaemoglobin (HbO2) to haemoglobin (Hb), know as the haemodynamic 
response function (HRF). The magnetic properties of Hb alter depending on whether 
or not it is oxygenated. Thus changes of Hb and HbO2 are detectable via BOLD 
response directly. Hb presence leads to microscopic field inhomogenenities that have 
a destructive effect on the signal from a voxel. This effect has a tendency to shorten 
the T2* relaxation time. Therefore, brain areas, which have currently enhanced blood 
flow due to greater neuronal activity, will have a longer T2*. This can then be seen as 
areas of increased signal relative to baseline.  
 
3.2  Echo-planar imaging 
Imaging the functioning brain rather than a structural image, requires rapid 
acquisition in order to capture the physiological change of interest at a similar rate. 
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Echo planar imaging (EPI) is a T2* sequence which collects data from an entire 
image slice following one RF pulse and introducing a rapidly changing magnetic field 
gradient. The benefit of EPI is the rapid acquisition of data, however it is at a cost of 
spatial resolution and increased risk of image artifacts and distortion. It is for these 
reasons that it is imperative to collect a standard T1 image at a higher resolution for 
registration purposes. 
 
4. Analysis of fMRI data 
There are multiple methods of analysis for fMRI data which depend upon the type of 
data collected (i.e. task-based or resting state), design protocol used (i.e. block, event 
related) and the existence of an a priori hypothesis or not (i.e. region-of-interest vs. 
whole brain). Two major software packages are commonly used for fMRI data 
analysis: Statistical Parametric Mapping (SPM; http://www.fil.ion.ucl.ac.uk/spm/) and 
FMRIB Software Library (FSL; http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/). 
 
4.1  Comparison of two major software tools 
Both SPM and FSL are well recognised and cited in the literature confirming their 
validity as software analysis tools.  It has also been reported that the results between 
the two software packages for various analysis techniques are similar although the 
analysis pipeline does differ slightly. For example, FSL performs normalisation after 
initial statistics in order to view activation on raw scans. Realignment consists of rigid 
body registration in both softwares but differ in cost functions used (SPM uses 
variance; FSL uses normalised correlation). Spatial smoothing is applied in both 
software packages differing in stage of implementation of temporal filtering; SPM at 
individual statistics using high pass filter 128s and FSL earlier with 100s. 
	   55	  
Normalisation does differ between the SPM and FSL.  SPM initially uses linear 
transforms before applying non-linear transforms whereas FSL uses only linear 
transformation. The latter approach is very robust but does produce a lot of residual 
error compared to SPM which is much more aggressive and requires a good structural 
scan for success. Both software packages adopt the general linear model (GLM) for 
individual statistics. At the group level, SPM uses only the estimates of contrasts 
whereas FSL uses both the estimates and the variability. The latter approach will be 
slightly more sensitive although will be more time consuming.  
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Figure 4. Analysis pipeline comparison 
 
Diagrammatic representation of a basic analysis pipeline for the SPM and FSL software 
packages. The main difference being the timing of the normalisation process.  
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4.2  Pre-processing of fMRI data 
Brain extraction 
Non-brain structures that cannot be accurately aligned in functional scans must be 
removed. This can be done using the brain extraction tool (BET) in FSL which 
removes the eyes, skull, tongue, sinuses etc from structural images using a surface 
model approach: a tessellated mesh of triangles is fitted to the brain surface (Smith 
2002). It is necessary to do this step, as functional scans will be normalised into 
standard space based on the structural scan information. 
 
Temporal filtering 
Temporal filtering allows the removal of noise from data with the aim to increase the 
signal to noise ratio. By using a high pass filter, low frequency noise that could be due 
to slow changes of the overall signal intensity, can be removed. Here, a high-pass 
filter of 128s (default setting) was implemented.   
 
Motion Correction 
Head movement is inevitable during a long scanning session despite the use of 
immobilising equipment, such as padding. This gradual shift needs to be rectified in 
order for registration into standard space to be accurate, as each voxel is required to 
be in the same location throughout the scanning session. Subject head movement is 
removed by aligning the EPI images to a common reference point (in FSL, this is the 
middle volume and in SPM the first volume) using rigid body transformation (six 
degrees of freedom). Motion outliers can be created and used in design matrices as an 
additional confound (nuisance regressors). Here, when using SPM, realignment 
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option was used and in FSL, the McFLIRT function was implemented (Motion 
Correction FMRIB’s Linear Registration Tool) (Jenkinson et al. 2002).  
 
Regressors for WM and CSF 
In order to eliminate noise generated from spurious activations in WM and CSF, 
masks were generated using FAST (FMRIBs Automated Segmentation Tool) which is 
part of the FSL software package. The FAST tool extracts the mean time series using 
fslmeants command and generates a text file for each mask to be included as a 
regressor in preprocessing steps.	   
 
 
Spatial smoothing  
Signal-to-noise ratio can be improved via smoothing. This process reduces variation 
in structural scans between-subjects and high frequency nose within-subjects. 
Typically a smoothing kernel of 5mm full-width half-maximum is applied to each 
volume of functional data and this parameter was applied to the data in this thesis. 
 
Registration and Normalisation 
Prior to group comparisons, the runs of each session need to be registered together 
and then all subject data is required to be registered into standard space. SPM uses a 
direct normalisation approach whereby the fMRI data is directly normalised to 
steroeotaxic space. FSL uses an indirect method involving the normalisation of the 
structural image into stereotaxic space. The parameters produced in the former step 
are then used for the normalisation of fMRI data into stereotaxic space. 
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4.3  Statistical Analysis 
The GLM is used to produce summary statistics at each level before being passed 
onto the next level. First level analysis considers individual sessions of data (‘runs’). 
In SPM, all runs can be analysed at the same time during one stage of first level 
analysis, however FSL requires individual runs are analysed separately, then 
combined in an intermediate level before moving on the higher level analyses. Higher 
level averages data across subjects or groups for comparisons. 
 
First level analysis 
Each run is analysed separately using voxelwise time series analysis within the 
framework of GLM. A synthetic HRF is generated as well as its first temporal 
derivative in order to shift the waveform in time to create a better fit to the data. A 
design matrix, requiring explanatory variables (EVs) is created describing the time 
course of each experimental condition within a run. For example, in this thesis I 
present a GLM design matrix for movement and no movement conditions and 
contrasts comparing EV’s such as movement vs. no movement. Each EV will result in 
a parameter estimate (PE) image that reflects how strongly the EV fits to the voxels 
within the image. To create a t-statistic image, the PE image is divided by its standard 
error and at this point a z-statistic image can be created.  
 
Higher level analysis 
During higher level analysis, the variance of each subject is accounted for, resulting in 
the probable group mean of the cohort and can be conducted using analysis of 
variance and post hoc t-tests. Comparisons between groups can be carried out using 
independent samples t-tests.  
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Thresholding 
Carrying out statistical tests at higher level analysis requires thresholding to show 
only voxels or clusters of voxels significantly activated. If all of the voxels in an 
image were to be considered independent then a Bonferroni correction could be 
applied. However, due to approximately 20,000 voxels within an image, the risk of 
type II error (falsely rejecting true activation) is increased. Thus, an alternative 
approach is to consider that each voxel is not independent and correcting according to 
the number of possible independent observations in a spatially smoothed area, which 
is biologically plausible. This cluster-based thresholding method is applied to 
neuroimaging data whereby a voxel can be considered significant if surrounded by a 
thresholded number of adjacent voxels. Therefore, the cluster-level threshold is 
dependent upon the level set for the peak-level threshold. In this thesis, a threshold of 
20 voxels was implemented. 
 
Region of interest (ROI) analysis 
When there is a clear a priori hypothesis, ROI analysis can be performed. First, a 
region needs to be defined which can be done via manual delineation or from atlases 
such a WFU Pickatlas, which contains pre-defined ROIs, based on a number of 
standardised anatomical scans. ROI analysis can also be used to extract data upon, i.e. 
such as time series information, which statistical analysis can be performed. In this 
thesis, anatomical ROIs for the fMRI data were used and manual delineation for the 
DTI data. 
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5. Analysis approaches for rsfMRI data 
A testament to its relative youth in neuroscience, there are as yet, no clear consensus 
for the optimal approach rs-fMRI data analysis.  Numerous methods have been 
developed and applied to rs-fMRI data in PD populations to assess functional 
connectivity and within-voxel oscillations. Seed based functional connectivity 
analysis involves placing a ‘seed’ in a specific ROI from which fluctuations of ROI 
BOLD signal are correlated with BOLD signal fluctuations in all other voxels of the 
resting brain. Hierarchical clustering has expanded seed-based functional connectivity 
analysis by using a correlation matrix of multiple seeds to determine which seeds are 
most closely related.  These functional connectivity approaches require strong a priori 
hypotheses and are advantageous from the perspective of interpretation in the context 
of neuroanatomy and disease processes. Data driven approaches consider all 
activation across the whole brain, such as graph theory, which mathematically derives 
global and local connectivity between brain regions resulting in a collection of 
‘nodes’, which are representative of brain regions, interconnected both spatially and 
functionally (Wang et al. 2010). ICA decomposes BOLD signal into separate source 
signals in a network-based approach (Esposito et al. 2008). The assumption that 
individual source signals will be statistically independent, each component therefore 
represents an independent network. Graph theory and ICA are free of a priori 
hypotheses and can remove physical noise from the rs-fMRI signal. ReHo analysis is 
dissimilar to ICA in that it considers short-distance functional connectivity by 
measuring time series similarity of one voxel with its nearest neighbour voxels (Zang 
et al. 2004). ALFF analysis provides an index of the amplitude of a given region 
within its network or location within a specified low-frequency range (Zang et al. 
2007). To date, only one analysis approach provides information on the directionality 
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of information flow: GCA or effective connectivity, due to its assumption that activity 
in one region causes activity in another region (Delaveau et al. 2010). 
It is clear that given the variety of analysis techniques and the heterogeneity of the PD 
population, effective comparison of the resting state literature and determining the 
optimal analysis approach in PD is complicated. However, in this thesis, a seed-based 
approach has been used due to the strong a priori hypotheses.  
 
6. Diffusion Tensor Imaging (DTI) 
6.1  Principles  
DTI offers a unique, non-invasive technique to assess the microstructure and anatomy 
of brain tissue through the characterisation of diffusion processes in water molecules. 
Diffusion is the random movement of particles i.e. water molecules, following 
thermally driven molecular collision. Within an unrestricted environment, water 
molecules are more equally able to travel in all directions. Conversely in a restricted 
environment, such as brain tissue, which contains myelin sheaths and cell membranes, 
such obstacles restrict diffusion. The amount of diffusion restriction varies among 
tissue types. For instance, white matter typically causes water molecules to travel 
along a specific direction due to the densely packed and homogenously oriented 
myelinated axon bundles. This is considered anisotropic diffusion whereas isotropy is 
a property referring to the orientation independence of diffusion.  
FA is a measure of anisotropy and refers to a value, between zero and one, which is 
used to quantify relative directional properties of the diffusion process. A higher 
fractional anisotropic value would indicate an ellipsoid that was ‘cigar shaped’, and 
indicative of a strong, linear directional diffusion, a value closer to zero would 
indicate a higher degree of isotropy. 
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Therefore, DTI can quantitatively measure diffusion properties within different tissue 
types and gather information regarding any degeneration, insult or reorganisation 
within brain tissue.  
 
6.2  Measuring diffusion with MRI 
Diffusion weighted MRI uses pairs of magnetic gradient pulses to detect water 
diffusion. The first gradient results in the dephasing of protons along the gradient 
axis, which is amount dependent upon the protons position along the magnetic 
gradient. After approximately 20-50 ms, the second gradient is applied which cancels 
out the dephasing caused by the first gradient. This rephrasing is also dependent upon 
the position of the proton along the gradient axis, therefore complete rephrasing the 
initial status does not occur and leads to a detectable loss of signal. The more 
diffusion along the direction of the applied gradient leads to a higher attenuation of 
signal compared to that obtained with no applied gradient (b=0). As such, a diffusion 
coefficient (D) can be calculated based on the signal intensity within each imaging 
voxel, where S is the signal intensity in the diffusion image and S0 is the signal 
intensity in the reference image (b0 image) and b is the diffusion weighted gradient 
factor (Mori et al. 2006): 
S = S0e-bD 
Critically, gradients must be applied along multiple axes to allow detection of water 
diffusion in different directions. Therefore, a DTI experiment will apply several 
diffusion gradients and the strength of these gradients is known as b (b-value). B 
values, which depend on the strength and duration of gradients, are critical to ensure 
enough signal can be detected whist attenuating the signal-to-noise ratio. The most 
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commonly used b value is 1000 sec/mm2 and can be adequately used in a variety of 
applications.  
 
6.3 Diffusion measures 
Basser et al., introduced diffusion tensor application as a description of anisotropic 
diffusion behaviour by a multivariate normal distribution model (Basser et al. 1994). 
This model reflects diffusion properties in both anisotropic and isotropic mediums 
meaning diffusion measures can be derived regardless of the location or direction of 
neural fiber. Therefore, the diffusion tensor is a 3 x 3 x 3 covariance matrix: 
 
   
 
 
 
As such, to describe the tensor in each voxel, six diffusion weighted images and one b 
value equal to zero are required (Bammer & Bammer 2003). Therefore, more 
diffusion directions applied increases the accuracy of the tensor measurement. The 
diffusion can be visualised as an ellipsoid with eigenvectors (v1, v2, v3) and 
eigenvalues (λ1λ2λ3) defining the diagonalisation and directionality of diffusivity at a 
given time. If the eigenvalues are (almost) equal then diffusion is considered isotropic 
and anisotropic if significantly different in magnitude. 
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The main diffusion tensor measures are: 
• Fractional anisotropy (FA), which measures the proportion of directionality in the 
tensor. Highly anisotropic structures will have an FA approaching ‘1.0’ while 
isotropic structures will have an FA approaching ‘zero’.  
 
 
 
• Mean diffusivity (MD), which is the sum of eigenvalues and represents overall 
diffusivity of molecules  
 
 
DTI does have its limitations. Water diffusion in the brain is perhaps a rather 
simplistic approach of study to a complicated organ such as the brain. Partial volume 
effects may be present due to tissues/substances other than white matter existing in an 
identified voxel. Areas of crossing fibres such as the centrum semiovale, where fibres 
of the corpus callosum, corona radiata, and superior longitudinal fasciculus form a 
three-fold crossing present issues in accurately defining the directionality within a 
voxel. However, sophisticated methods of analysis are being developed to over come 
problems such as crossing fibers, hopefully allowing greater assessment of diffusion 
indices in these problematic areas. DTI data is prone to artifacts, particularly related 
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to motion of the subject, as well as eddy currents due to the rapid switching of 
diffusion gradients, which are high in amplitude.  
7. Analysis of DTI data 
There are four basic approaches for DTI data analysis: VBA, ROI analysis, whole 
brain histogram analysis and tractography.  
Pre-processing steps for DTI data analysis are broadly similar to those previously 
described for fMRI (Chapter 2). In general, raw data is transformed to the appropriate 
format depending upon the software of use and brain extraction is applied to remove 
all non-brain voxels. For DTI data, it is particularly important to apply motion 
correction for subject motion and eddy current correction for image distortions. Eddy 
currents are localized electric currents induced by varying the magnetic field in the 
scanner, which can cause stretches, and shears in the diffusion weighted images.  
Geometric distortions may be caused due to misalignments in the individual diffusion 
weighted images comprising a total data set. Eddy current correction will correct for 
these artifacts. Furthermore, data is corrected by affine registration to the b0 image, 
which is of particular importance when scanning tremulous PD patients. Finally, 
calculating a diffusion tensor within each voxel generates FA and MD maps. 
In this thesis, two approaches were used. Due to a strong a priori hypothesis, ROI 
analysis using DTIExplore and TrackVis were implemented to extract measures of 
diffusion (FA and MD) from individual diffusion maps to be used for statistical group 
analyses. ROIs were manually delineated by two experienced imaging scientists for 
caudate, putamen and SN using the co-registered T2-weighted image of the selected 
individual for anatomical guidance. Anatomical borders for SN followed that of 
outlining hypointense region between cerebral peduncles and posterior tegmentum on 
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three slices.  VBA was also performed in SPM12 to examine the entire brain in single 
subjects and perform group statistics. 
 
8. Scanning protocol 
8.1 Description of scanning sessions 
All patients underwent a baseline scanning session, which consisted of structural 
brain imaging including T1 and a 64-direction DTI scan. Functional imaging 
consisted of two runs of a motor task paradigm interjected by a single rs-fMRI 
sequence. A proportion of the subjects returned for a follow-up scanning session that 
consisted of the exact same protocol. All scanning sessions were conducted on a 3T 
Trio Siemens scanner (Siemens Magneton, Erlangen, Germany) equipped with a 32-
channel head coil at Imanova Ltd. 
 
8.2 Scanner parameters 
Structural T1 
One high-resolution T1-weighted turbo field echo structural scan was collected (TE 
2.98 ms; TR 2300 ms; 9° flip angle; FOV 256 mm). 
 
Functional MRI 
Whole-brain data were acquired with 160 volumes of T2*- weighted gradient-EPI in 
ascending order with an automated higher-order shim procedure [slice thickness 3.0 
mm; repetition time (TR) 2500 ms; alternating long and short echo time (TE) 13 ms, 
31 ms; 80° flip angle; field of view (FOV) 192 mm]. The slice acquisition angle was 
set at 0° from the anterior-posterior commissure (AC–PC) line to reduce frontal lobe 
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signal dropout due to the air sinuses, with a z-shim gradient correction to compensate 
for through-plane susceptibility gradients (Deichmann et al. 2003). 
 
DTI 
Integrated parallel imaging (GRAPPA) was used with two-fold acceleration. Seventy 
axial slices were obtained: TR = 9300 ms; TE = 88ms; acquisition matrix: 128 x 128; 
FOV= 240 mm; voxel size = 1.875 x 1.875 x 1.9mm and 1.9mm slice thickness. 
Diffusion sensitizing gradients were applied to 64 non-collinear directions with a b-
value of 1000s/ mm2 and a non- diffusion weighted image with b = 0s/ mm2 was 
obtained. The present protocol was optimal at time of sequence development; 
however, advances regarding higher b0 values suggest the current protocol may 
reduce accuracy of tissue characterisation.  
 
8.3  Motor Task Paradigm 
All PD patients completed a motor execution paradigm in the scanner using an in-
house built joystick, placed on the most clinically affected side, consisting of two 
conditions: “movement” and “no-movement”. Trials were presented on a screen 
starting with a centered black circle and four directional black arrows (north, east, 
south, west) on a grey background (Figure 5). During the movement condition the 
patient was presented with a preparation stimulus (black circle turning green) for 2 s 
followed by a movement cue stimulus of one directional arrow turning green for 4 s. 
PD patients were requested to move the joystick in a single movement following the 
cue in the direction presented. This condition accounted for 80% of the trials (80 
trials; 20 north, 20 east, 20 south, 20 west). The no-movement condition consisted of 
the patients holding the joystick and looking at the preparation stimulus but not 
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instructed to make a movement. This condition accounted for 20% of the trials (20 
trials). The paradigm consisted of a single run lasting twenty minutes, interjected with 
a rest period half way through, totaling 100 trials.  
 
 
Figure 5. Motor Paradigm 
 
A = Example of a ‘north’ movement trial  i) Subject is presented with a grey background with a black 
centering circle and four directional black arrows for an inter-trial interval (ITI) (mean 6 s, due to 
event-related design) ii) Following the ITI, the preparation stimulus of the black circle turning green is 
presented for 2 s iii) The north arrow turns green for 4 s, during which time, the subject is required to 
move the joystick in a single movement, north iv) The ITI is presented again before the next trail 
begins. B = Example of a ‘no-movement’ movement trial i) Subject is presented with a grey 
background with a black centering circle and four directional black arrows for an inter-trial interval 
(ITI) (mean 6 s, due to event-related design) ii) Following the ITI, the preparation stimulus of the black 
circle turning green is presented for 2 s iii). The ITI returns, i.e. none of the arrows turn green 
indicating no movement is expected.  
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8.4  The joystick 
The in-house joystick was designed specifically for this motor paradigm to allow 
collection of behavioural data. The joystick location in relation to its axes was 
recorded every 10ms throughout each movement trial for each run, ultimately 
producing a log file (Figure 6, A). The data within each logfile from each run could 
then be averaged and visualized through an in-house Matlab code (Figure 6, B and C) 
permitting quality control and extracting of individual performance for motor 
execution and amplitude to be used in group statistics.  
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Figure 6. Extracted behavioural data from joystick 
 
 
Examples of log files produced from in-house joystick programme. A = screenshot of logfile portion. 
Positional data at each 10 ms time point is collected throughout the scan which can be collated to 
provide motor execution and motor amplitude data for each subjects.. B = well performed task with 
movements in the correct direction and in a smooth manner and C =  poorly performed task with 
errors of direction and tremor. 
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8.5  Behavioural Motor Data 
Measures of motor execution and motor amplitude were collected from the joystick 
during the motor task scanning session. Motor execution was defined by the time (ms) 
it took each subject to move from starting position to their peak movement (furthest 
point from initial position before returning the joystick, thus completion of 
movement). The peak movement described above defined motor amplitude. These 
measurements were collected for each movement trial for both runs and averaged for 
statistical analyses. 
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CHAPTER 3:  BASELINE MOTOR NETWORKS IN 
PARKINSONS DISEASE 
1. Introduction  
Parkinson’s disease (PD) is a neurodegenerative disease characterized by the presence 
of Lewy bodies resulting in the loss of dopamine (DA) neurons in the substantia nigra 
pars compacta (SNc) and the subsequent deficiency in striatal DA, which is required 
for the effective execution and control of movements. Neuroimaging studies using 
PET and functional magnetic resonance imaging (fMRI) to investigate motor 
execution in PD commonly report a hypoactivation of the supplementary motor area 
(SMA) and hyperactivation of primary motor area (M1), premotor area, parietal lobes 
and cerebellum (Playford et al. 1992; Jahanshahi et al. 2010; Rascol et al. 1992; 
Haslinger et al. 2001; Buhmann et al. 2003). It is suggested that findings of 
hyperactivation may reflect compensation mechanisms attempting to overcome the 
extra difficulty for patients to complete motor actions (Grafton 2004). However, 
despite a relatively large number of neuroimaging investigations, the neural course of 
motor execution decline and/or compensation in PD is still unclear. In recent years, a 
move away from solely investigating changes in magnitude of brain activity but the 
relationships and interactions between regions during motor execution has become an 
important component of PD research. Assessing interregional associations of the 
multi-regional motor network will provide valuable information of neural processes 
underlying PD pathophysiology. As such, studies of altered motor network 
connectivity in PD with conclusions of compensatory mechanisms have been reported 
in recent year (Wu & Hallett 2005; Wu, Wang, et al. 2011). The aforementioned 
studies are blighted by small sample sizes compared to healthy controls only thus 
inferences of connectivity as a result of the disease course cannot be made. 
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A further advancement of functional connectivity in PD has been made in recent years 
in the form of resting-state fMRI (rs-fMRI). Studying the brain at rest in an attempt to 
understand its spontaneous neural activity without constraints inextricably linked to 
task-based studies (i.e. subjects ability to perform the task, presence of attention-
based stimuli) (Biswal et al. 1995; Raichle et al. 2001) is a valuable non-invasive tool. 
Thus a number of rs-fMRI studies in PD have been undertaken with general reports of 
disruption of the motor networks in PD (Wu, Wang, et al. 2009) and possibly 
reorganisation of cortico-striatal loops due to disease processes (Helmich et al. 2010).  
From the previous literature it is clear that it is important to continue considering 
magnitude of brain activity changes but to also investigate functional connectivity in 
both the active and resting state. It is presumed that a disrupted resting network will 
have a deleterious effect on the active state, such that it may not be effectively primed 
to initiate or execute future movements. Similarly, a resting state network 
experiencing compensatory mechanisms may be beneficial to the active motor 
network. Furthermore, to elucidate the effect of disease processes and 
symptomatology on these networks, sizable cohorts of varying stages of disease are 
required. To date, no study has used fMRI to comprehensively assess the neural basis 
of active and resting motor execution dysfunction or compensation as a function of 
disease course.  
Here, we have undertaken an established motor task fMRI paradigm (Jenkins et al. 
1992) in 76 PD patients divided by quartiles according to their Unified Parkinson 
Disease Rating Scale Part-III (UPDRS-III) score. By completing voxel-by-voxel 
analysis and a functional connectivity analysis across groups, we aimed to explore 
regional BOLD signal reductions across the disease course as well those, which 
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possess compensation activity. Assessment of functional connectivity of the resting 
network has also been investigated in a sub-set of 56 PD patients to ascertain if 
underlying intrinsic networks are related to the functioning of the active neural state.  
There is no consensus on sample size in fMRI studies. However, reports suggest 
between 12 and 36 subjects could be optimal  (Friston et al. 1999; Desmond & Glo 
2002). It is likely larger sample sizes are required for multiple comparisons 
(considering both voxel-by-voxel comparison and subject/group comparison). 
Division of the current cohorts into four groups is currently within the realms of 
acceptability regarding sample size.  
 
2. Aims 
The aims of this chapter were to: 
- Identify the neural motor network in a large group of PD patients; 
- Characterise stages of aberrant neural motor dysfunction in PD as a 
consequence of disease severity; 
- Identify possible compensatory processes occurring as a response to the loss 
of normal motor neural functioning. 
- Use behavioural in-scanner information to assist interpretation of neural 
findings. 
 
3. Hypotheses 
The hypotheses were that: 
- The joystick paradigm will sufficiently elicit recruitment of the neural motor 
network; 
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- There will be gradual decline of BOLD signal in these regions as disease 
severity increases; 
- PD patients with greater disease severity will recruit neighbouring regions to 
compensate for neural motor network dysfunction. 
 
4. Patients and Methods 
4.1 Patients 
Seventy-six non-depressed, non-demented PD patients underwent a single fMRI 
scanning session involving an in–scanner motor task and 56 PD patients underwent 
rs-fMRI. Twenty rs-fMRI datasets were excluded due to a high degree of signal 
dropout surrounding the frontal sinuses area and deemed unfit for analysis. PD 
patients were recruited from three UK centers (Imperial College London, London, 
University College London, London and University of Cambridge, Cambridge) and 
one European center (Skäne University Hospital, Lund, Sweden) of the FP7 EC 
TransEuro. Recruitment onto the study was dependent upon at least one year disease 
duration and less than 10 years, ability to be MR imaged and an AIMS (abnormal 
involuntary movement scale) score less than 2. All PD patients fulfilled the UK brain 
bank criteria for PD (Hughes et al. 1992). The clinical battery included H&Y staging, 
the motor part of UPDRS (UPDRS-III), MMSE and calculation of L-dopa-
Equivalent-Dose (LED). PD patients were divided into four groups according to 
disease severity, as measured by UPDRS-III and assigned a disease burden score (1 
being the lowest and 4 being the highest) (Tables 4 and 5). Groupings were created 
according to quartiles calculations.  
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PD patients were divided into four groups according to disease severity, as measured 
by the UPDRS-III and assigned a disease burden score (1 being the lowest and 4 
being the highest). Groupings were created according to quartiles calculations. 
 
Table 4. Patient characteristics undergoing motor task fMRI. 
 DB 1 DB 2 DB 3 DB 4 
P value 
DB 1 vs 
DB 2* 
P value 
DB 2 vs 
DB 3* 
P value 
DB 3 vs 
DB 4* 
 
No of subjects 19 19 19 19 - - - 
Sex 
Male:Female 
15:4 13:6 15:4 17: 2 - - - 
Age (years ± 
SD) 
55.1± 
7.3 
56.6 ± 
6.9 
56.1 ± 
6.1 
57.1 ± 
8.5 
ns ns ns 
Disease 
Duration 
(years ± SD 
4.16 ± 
1.45 
4.38 ± 
2.1 
5.7 ± 2.9 
6.78 ± 
2.5 
ns ns ns 
H&Y OFF 
1.7 ± 
0.4 
2.0 ± 0 2.0 ± 0 2.0 ± 0 >0.05 ns ns 
UPDRS-III 
OFF 
17.5 ± 
2.6 
25 ± 2.4 
33.4 ± 
2.2 
46.6 ± 
5.1 
>0.000 >0.000 >0.000 
Total LED 
410 ± 
191.2 
414.8 ± 
200.5 
562.4 ± 
331.3 
637 ± 
288.9 
ns ns ns  
Patient characteristics demonstrating subjects are matched for demographic and clinical data apart 
form UPDRS-III OFF score which was the grouping criteria. *All p values derived from unpaired t 
tests; SD = standard deviation; UPDRS-III = Unified Parkinson’s Disease Rating Scale Part III; LED 
= Levodopa equivalent dose; MMSE = mini mental state examination; DB = disease burden. 
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Table 5. Patient characteristics undergoing resting state fMRI. 
 
Group 
1 
Group 2 
Group 
3  
Group 
4 
P value 
Group 1 
vs Group 
2* 
P value 
Group 2 
vs Group 
3* 
P value 
Group 3 
vs Group 
4* 
 
No of subjects 14 14 14 14 - - - 
Sex 
Male:Female 
11:3 9:5 10:4 12: 2 - - - 
Age (years) 
54.7 ± 
7.8 
56.3 ± 
7.3 
58.1 ± 
5.6 
59.4 ± 
6.8 
ns ns ns 
Disease 
Duration 
(years ± SD) 
3.99 ± 
1.6 
4.59 ± 
2.2 
4.52 ± 
2.6 
5.6 ± 
1.6 
ns ns ns 
H&Y OFF 
1.7 ± 
0.4 
2.0 ± 0 2.0 ± 0 2.0 ± 0 >0.05 ns ns 
UPDRS-III 
OFF 
17.9 ± 
2.9 
24.07 ± 
1.6 
31. 4 ± 
2.7 
46.1 ± 
6.6 
>0.000 >0.000 >0.000 
Total LED 
329.1 ± 
158.4 
455.27 ± 
189.7 
418.2 ± 
294.5 
672.2 ± 
288.5  
>0.05 ns 
>0.05 
 
Patient characteristics demonstrating subjects are matched for demographic and clinical data apart 
form UPDRS-III OFF score which was the grouping criteria and H&Y scores. *All p values derived 
from unpaired t tests; SD = standard deviation; UPDRS-III = Unified Parkinson’s Disease Rating 
Scale Part III; LED = Levodopa equivalent dose; MMSE = mini mental state examination; DB = 
disease burden. 
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4.2  Scanning procedure 
PD patients were scanned in morning sessions (between 10.00 and 13.00 h) in the 
practically defined OFF condition following withdrawal of medication at least 18h 
prior to scanning, or 36h if using a prolonged released form of medication. Image 
acquisition was conducted as per the descriptions detailed in Chapter 2. All subjects 
conducted the motor task paradigm as detailed in Chapter 2 and a single rs-fMRI 
acquisition. 
 
4.3 Behavioral motor data 
Measures of motor execution and motor amplitude were collected from the joystick 
during the motor task scanning session. Motor execution was defined by the time (ms) 
it took each subject to move from starting position to their peak movement (furthest 
point from initial position before returning the joystick, thus completion of 
movement). The peak movement described above defined motor amplitude. These 
measurements were collected for each of the trials for both runs and averaged for 
statistical analyses. 
 
4.4 Image analysis 
Rigorous quality control was done on all images. Image analysis for motor task fMRI 
data was conducted with using Statistical Parametric Mapping version 8 (Wellcome 
Department of Imaging Neuroscience, UCL, UK). Preprocessing stages included, 
discarding the first five volumes of each fMRI run to allow for equilibrium effects, 
realignment of all functional scans to the first scan of the run and then again to the 
mean of the all the volumes for motion and slice-time correction (all scans were 
included in the final analysis due head movement in any direction being  <2 mm), 
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coregistration of the mean functional image to the T1 structural scan, normalization to 
MNI space using parameters for the segmented T1 structural scan and smoothed using 
an 8 mm full-width at half-maximum Gaussian filter.  
Image analysis for rs-fMRI data was completed using MELODIC, part of the FSL 
package (release 5.0.4, http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FSL). The images were 
motion corrected and un-warped using the field map and were subsequently submitted 
to the standard processing steps: skull stripping, grandmean scaling (putting all time 
series on a common scale by normalising the mean of all voxels [over space and 
time]t to 100), temporal filtering (0.01-0.1 Hz), normalization and registration. 
 
4.5 Statistical analysis 
Voxel- based comparisons for motor task activation differences were performed 
between groups using two sample t-tests in SPM8. Contrasts created in a general 
linear model (GLM) for each movement vs. no movement condition, which included 
motion and movement parameters. These contrasts were used for the second level, 
group random effects analysis. Initially a statistical threshold of p < 0.001 uncorrected 
and cluster extent over 20 voxels was used for activation using whole brain analysis 
with corrections for multiple comparisons using the false discovery rate at p< 0.05. 
Peak voxel activation was determined at the group level for four groups divided 
according to severity.  
Functional connectivity analyses for both motor and rs-fMRI analyses were 
performed with FSL. A mean time series was obtained from each a priori seed region 
(caudate, putamen, M1, premotor area, SMA, thalamus, pallidum, dorsolateral 
prefrontal cortex [DLPFC], somatosensory cortex) by averaging the time series of 
every voxel within the ROI prior to smoothing in functional native space.  A Pearson 
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r correlation coefficient map was produced for each comparison. There is an 
acknowledged degree of variance in task-activated fMRI time-series data (Gavrilescu 
et al. 2008). Therefore, motor task data were converted to z maps using Fisher’s r to z 
transformation to account for this variance. 
Behavioural motor data were extracted from the scanner output logfiles using an in-
house code for Matlab. Statistical analyses for behavioural motor data, clinical and 
demographic data were performed using SPSS (version 16, SPSS Inc) for Macintosh. 
Comparisons between groups were performed using two sample t-tests. 
 
5. Results 
5.1 Participants 
PD patients undergoing motor task fMRI analyses were not significantly different 
between groups for age, disease duration, total LED. DB 1 and DB 2 were marginally 
significantly different for H&Y scores (p< 0.05) and all groups were significantly 
different for UPDRS-III scores (p<0.0001). PD patients undergoing the rs-fMRI 
analyses were not significantly different between groups for age or disease duration. 
Similar to the motor-task fMRI group, DB1 and DB2 were marginally significantly 
different for H&Y scores (p < 0.05), as well as total LED (p< 0.05). All groups were 
significantly different for UPDRS-III score (p <0.0001)    
 
5.2  Behavioural: Motor execution and amplitude 
PD patients generally showed deficits in both motor execution and amplitude between 
lower and higher disease burdens indicated by the slower reaction time and less 
distance respectively. Both motor measures indicate a worsening between DB 2 and 
DB 3, although the observed effect was no significant (figure 7). 
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Figure 7. Behavioural motor results across disease burden in PD patients 
 
 
Motor Execution = mean reaction time (ms) for subject to move the joystick from its starting position 
to its peak movement (furthest point form initial starting position) with standard deviation. Motor 
Amplitude = mean distance from initial starting point to furthest point indicating completion of 
movement. Measurements taken from ‘movement’ conditions only and averaged across all trials in 
both runs. Results show lower DB stages have slower reaction time and have lower amplitude 
compared to higher DB stages. 
 
 
5.3   fMRI motor execution and disease burden: voxel-by-voxel-analysis 
Whole brain analysis revealed that PD patients with DB 2 vs. DB 1 have reduced 
BOLD signal in M1, caudate, putamen, somatosensory cortex, premotor area, SMA 
and thalamus (p < 0.01) during motor execution vs. no movement. Patients with DB 3 
vs. DB 2 show significant BOLD signal reductions, which were detected in M1, 
premotor area (p<0.01), putamen and left somatosensory cortex (p<0·05) with an 
additional decrease in the right DLPFC (p<0.05). 
PD patients with DB 4 vs. DB 3 no longer revealed significant BOLD signal 
decreases but rather, BOLD signal increases are detected in the same or neighboring 
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regions (premotor area, SMA, DLPFC [0<0.01], caudate, thalamus [p<0.05]). ROI 
analysis confirmed findings of the whole brain analysis (Table 6, Figure 8). 
 
Table 6.  Significant ROIs with BOLD signal changes as a consequence of disease 
burden 
Disease burden 
comparison 
Region MNI Z Score 
2< 1 M1 413, -19, 40 3.58** 
Left Caudate -10, -2, -24 2.70** 
Left Putamen -28, -16, 12 3.46** 
Right Somatosensory 42, -22, 40 3.45** 
Thalamus 10, -24, 6 3.09** 
Left Premotor area -62, 8, 46 2.83** 
Right SMA 12, -6, 46 3.03** 
3 < 2 M1 -24, -16, 48 2.45** 
Right DLPFC  54, 10, 22 2.39** 
Putamen -22, -2, 4 2.17* 
Left Somatosensory -42, 20, 56 2.28* 
Premotor 8, -16, 66 2.55** 
4 < 3 No significant regions 
4> 3 Premotor area -40, 08, 36 3.48** 
 SMA 6, -14, 52 2.72** 
 DLPFC 44, 26, 22 2.99** 
 Caudate 18, 9, 13 2.59* 
 Thalamus -9, -14, -4 1.94* 
 
Significant BOLD signal changes in the motor network during movement vs rest in PD patients. Lower 
DB stages have significant hypoactivations in motor areas which appears to be restored at higher DB 
stages. All cluster corrected, thresholded at 20 voxels; * p<0.05; **p<0.01; MNI Montreal 
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Neurological Institute coordinate space; M1 = primary motor area; DLPFC = dorsolateral prefrontal 
cortex; SMA = supplementary motor area;  
 
Figure 8. BOLD signal changes as a consequence of disease burden 
 
Transverse sections of parametric maps showing significant BOLD signal decreases (blue-white) in 2 
> 1: M1 **; left caudate**; left putamen**, right somatosensory cortex**; thalamus**; left 
premotor**, right SMA**. 3 < 2: M1**; right DLPFC*; premotor**; putamen*; left somatosensory*. 
4 > 3: premotor**; SMA**; DLPFC**; caudate*; thalamus*. 1 = disease burden 1; 2 = disease 
burden 2; 3 = disease burden 3; 4 = disease burden 4.  Results show significantly reduced activations 
in motor related regions in lower DB stages compared to significantly increased activation in motor 
region at the higher DB stage. Colour bar indicates z scores. * = p < 0.05; ** = p < 0.01; *** = p < 
0.001, cluster corrected, thresholded at 20 voxels. 
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5.3 fMRI motor execution and disease burden: functional connectivity 
 
DB 2 vs. DB 1 showed generalized reduction of functional connectivity in motor 
networks with significant decreases between premotor and caudate (p <0.05), 
premotor and M1 (p < 0.03) and DLPFC and SMA (p<0.03). As DB increases (DB 3 
vs. DB 2) there are significant increases in connectivity between thalamus and 
putamen (p < 0.01), caudate (p < 0.01), SMA (p < 0.05), M1 (p< 0.01), premotor (p< 
0.01), DLPFC (p<0.01) and somatosensory cortex (p< 0.01); SMA and pallidum 
(p<0.05), caudate (p< 0.04); M1 and caudate (p<0.02); premotor an caudate (p<0.01); 
somatosensory cortex and putamen (p<0.02), SMA (p<0.01) and premotor (p< 0.01). 
At the highest DB (DB 4 vs. DB 3), a generalized increase of connectivity remains 
but a significant loss of previously restored regions is observed between M1 and 
thalamus (p<0.02); somatosensory cortex and pallidum (p<0.02) and M1 (p<0.05) 
(Figure 9). 
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5.5  Rs-fMRI and disease burden: functional connectivity 
ROIs identified during the motor fMRI task as being involved in significant BOLD 
changes within the motor network were used to define the rs-fMRI motor network. 
Correlation analysis applied to the extracted time-series data revealed a generalized 
decrease of connectivity at lower disease burdens (DB 2 vs DB 1) which gradually 
and regionally increases as disease burden increases (DB3 vs. DB 2) becoming 
significantly increased at the highest disease burden (DB 4 vs. DB 3) for seven ROI 
pairs: M1-thalamus, p < 0.03; M1-pallidum, p < 0.03; M1- putamen, p < 0.01; 
putamen-SMA, p < 0.02; putamen-premotor area, p < 0.01; putamen- somatosensory 
cortex, p < 0.03; somatosensory cortex-thalamus, p < 0.03 (figure 10). 
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Figure 9. Functional connectivity of A) motor task fMRI and B) resting motor 
network 
A.  
 B.  
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Functional connectivity analyses. A) Fisher z-transformed correlation co-efficients for the functional 
connectivity between motor related regions during the fMRI motor task. Showing significant decreases 
between DLPFC, caudate, premotor and M1 at lower DB stages. Significantly increased connectivity 
primarily from thalamus and somatosensory areas to the rest of the network at middle DB stages and 
then significant loss of connectivity M1, somatosensory, DPFC and premotor area at the higher DB 
stages. B) Pearson r correlation maps for the functional connectivity between motor related regions 
during the rs-fMRI scan. Showing significant increases in connectivity between M1, premotor, 
somatosensory, pallidum, putamen and caudate at higher DB stages. Groups according to disease 
burden (DB). Red = increased connectivity as disease burden increases; blue = decreased connectivity 
as disease burden increases. SMA = supplementary motor area; M1 = primary motor area; DLPFC = 
dorsolateral prefrontal cortex. Significant correlation indicated by bold asterisk. Pearson r 
correlation, p < 0.05.  
 
 
6. Discussion 
The present study, for the first time to our knowledge, investigated the change in 
magnitude of motor related neural activity as well as functional connectivity of the 
motor network in both its active and resting state in large cohort spanning four disease 
burden levels.  
Our results demonstrate that behaviorally, PD patients’ performance of motor 
execution and motor amplitude is defected as a consequence of DB. Specifically, 
there is a significant decline in motor execution performance as measured by reaction 
time between DB 2 and DB 3, which is maintained at DB 4. A similar trend is 
observed for motor amplitude performance.  
Following a voxel-by-voxel-analysis of the fMRI motor task, significant changes of 
BOLD signal (regional amplitude) are observed at DB 2 compared to DB 1 with 
reductions in M1, premotor area, somatosensory cortex, SMA, putamen, caudate and 
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thalamus. Significant reductions in M1, premotor, somatosensory cortex and caudate 
persist at DB 3 with additional reductions found in DLPFC. Interestingly, at DB 4, no 
significant reductions are found compared to DB 3 but rather significant increases are 
located within premotor area, SMA, DLPFC, caudate and thalamus.  
To investigate further and elucidate the relationship between these regional changes, 
functional connectivity analyses of the fMRI motor task were undertaken. Regional 
correlations reveal a generalized decrease of functional connectivity at DB 2 
compared to DB 1. Significant reductions were located between premotor area, M1, 
caudate, DLPFC and SMA.  Conversely DB 3 compared to DB 2 revealed a multitude 
of significantly increased functional connections existing between thalamus, putamen, 
caudate, M1, premotor, DLPFC, somatosensory cortex, pallidum. These results are 
highly indicative of compensatory mechanisms occurring to account for the increased 
difficulty to complete motor activities due to disease processes. This theory is upheld 
by the behavioral data not showing an increase in motor performance, thus increased 
connectivity in the active motor network is not permitting increased motor 
performance but more likely possessing a reserve property to allow continuation of 
motor abilities at a reasonable level. However, by DB 4, this reserve capacity appears 
to be declining with significantly reduced connectivity between M1, thalamus, 
somatosensory cortex and pallidum. The functional connectivity results are in line 
with the voxel-by-voxel-analysis but do show that the underlying functional 
connectivity may be altering in a more dynamic fashion, which is not observable at an 
isolated regional neural level until sometime later. This is evidenced by the observed 
increases at DB 4 in the voxel-by-voxel-analysis compared to the already declining 
connectivity analysis in the same group comparison.       
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Identification of compensatory mechanisms in PD is important for the development of 
biomarkers and to tailor endpoints and interpretation of clinical trials. However, 
compensatory mechanisms at the macroscopic level in PD are under-researched. This 
is mainly a consequence of the difficulty regarding methodology but the advances 
made in neuroimaging techniques enables better investigation of such processes. 
Indeed, animal models of PD suggest parkinsonian syndromes cannot be solely 
attributed to dysfunction within the basal ganglia (Chesselet & Delfs 1996) with 
strong evidence of biochemical changes in the nigrostriatal pathway serving as 
maintenance of DA transmission homeostasis (Zigmond et al. 1990). Neuroimaging 
techniques do not appear to correlate well with clinical measures of disease severity 
i.e. UPDRS-III and the progression of PD is affected by many factors such as age of 
onset, disease sub-type. (Marras & Lang 2008) However, it cannot be excluded that 
individual compensatory mechanisms are responsible for the variable rate of disease 
progression (Palmer et al. 2010). Indeed, recent fMRI studies have attempted to 
investigate compensatory mechanisms in PD with reports of cerbello-thalamo-cortico 
loop recruitment as a compensation of dysfunctional basal ganglia loops (Palmer et al. 
2010). The concept of motor reserve in PD; the ability of the brain to continue 
functioning via enhanced recruitment of typical regions and/or recruitment of novel 
regions until the dysfunction reaches a critical threshold, has been previously 
investigated in one fMRI study (Palmer et al. 2009). The authors demonstrated that 
when performing a motor task, PD patients maximally recruited the motor network 
and compensated for task difficulty by recruitment of novel areas (Palmer et al. 2009). 
Conclusions from the authors are in line with the current study as well as similar work 
in stroke (Mulder et al. 2002); increased effort required to maintain a suitable 
functional output leads to the activation of motor reserve.  
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Functional connectivity analysis of the resting motor network revealed theoretically 
agreeable findings to that of the active motor network. In general, there is a decrease 
of connectivity at lower disease burden, which gradually increases until significantly 
increased connectivity between M1, pallidum, putamen, SMA, premotor area, 
somatosensory cortex and thalamus are detected at DB 4. The active motor network is 
hypothesized to be dependent upon the resting motor network by virtue of modulating 
the effectiveness to prepare, initiate and execute any given action.  In the healthy 
brain, motor networks are required to maintain a resting state equilibrium in order to 
perform future motor tasks (Bressler & Kelso 2001). Thus, a disrupted or 
compensated resting motor network should have an effect on the effective initiation 
and execution of movements. It should also be considered that the presence of 
dyskinesia could have an influence on motor networks (active or resting) through 
further disruption of reorganisation. Due to the lack of dyskinesia in the current 
cohort, this could not be explored in the current study.  
Multiple brain regions are well established as being part crucial in the effective 
control of movements, namely M1, premotor area and SMA. The SMA is indeed 
important for motor preparation and initiation. Typically this region is reported to 
possess a hypoactivation or decrease in activation rather than the increase that we 
have reported.  Our motor paradigm was more focused on motor execution than 
preparation or initiation, thus a decrease may not be completely expected. It has also 
been previously suggested that an increase in SMA activity could be directly 
proportional to speed of movement (Riecker et al. 2003). Considering our patients had 
a significant reduction in reaction times for movement completion, we are confident 
that our increased SMA finding is not related to an increased speed of movement 
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effect. However, one of the few rs-fMRI studies in PD does corroborate our findings 
(Wu et al., 2010b).  The premotor area is involved in selection and generation of 
movements (Grafton et al. 1997) and has been reported to demonstrate decreased 
connectivity in the resting motor network (Wu et al. 2010). Here, we report an 
increase but not in M1. Thus it is likely that the disruption of the central motor region 
(M1) may lead to compensatory mechanisms in associative motor cortices.  
The DLPFC has also been previously reported as possessing decreased functional 
connectivity with other motor related regions (Wu, Long, et al. 2009). The DLPFC is 
typically involved in processes related to attention of action performance monitoring. 
The fact we found an increase and not a decrease in this region in isolation and within 
connectivity analysis, could simply indicate that our subjects were of a high cognitive 
ability or that compensatory mechanisms are also in place for non-motor and motor-
related processes.  
It should be noted that the current data detected an apparent delay between the 
restoration of functional connectivity in the active motor network and resting 
network. This could be due to a genuine delay in the restoration of networks or due to 
methodological reasons related to the extraction of highly correlated time courses in 
the resting data. An alternative explanation could be related to the increased 
attentional load likely to be required for the completion of motor tasks, thus the active 
motor network is detecting an increase of functional connectivity in motor- attentional 
areas to compensate for the higher demand motor tasks require as disease burdens 
increases.  
Due a strong a priori hypothesis regarding ROIs for this study, our results directly 
answer the question at hand: how are motor related networks affected in PD due to 
disease burden. However, it should be noted that pre-chosen ROIs always present the 
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possibility of bias and complete removal of physiological noise is limited. Therefore, 
future studies may wish to take a whole brain approach whereby robust de-noising 
approaches can be applied to the data to ensure the effects of non-neural physiology, 
scanner artefacts and other confounds are accounted for. By doing so, the data can be 
less likely to contain spurious correlations. 
Here, we have shown for the first time, magnitude and connectivity changes in the 
active and resting motor network in a large cohort of PD patients across various DB 
stages. Collection of in-scanner behavioral data not only aids quality control of data 
i.e. ensuring subjects are completing the task effectively, but allows cross-checking of 
neural information with actual symptomatology, i.e. increased activation in a certain 
brain region does not necessarily mean an enhanced performance on the task. This 
study is limited by the lack of control subjects thus not permitting the comparison of 
normalization effects. Furthermore, conducting whole brain connectivity analyses 
could enhance the study because despite possessing strong a priori hypotheses, it 
cannot be discounted that region-to-region introduced bias.  
This study highlights the need to utilise all stages of PD to fully elucidate the 
underlying neural mechanisms due to and coping with the disease process. Future 
studies should consider the use of cohorts with multiple disease stages to investigate 
motor network evolution in PD in both the active and resting state. Furthermore, this 
study indicates the importance of using more than one imaging modality and analysis 
technique to capture the full extent of PD network alterations.  
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CHAPTER 4:  MOTOR NETWORKS IN PARKINSONS DISEASE 
OVER TIME 
1. Introduction 
In line with Chapter 3, the focus of the current chapter is to elucidate the course of 
neural motor network dysfunction in PD patients.  To date, fMRI investigations of 
motor control and the motor network in PD have elucidated significant differences in 
BOLD signal between PD patients and healthy controls in the striatum and cortical 
areas such as M1, SMA and IPL (Buhmann et al. 2003; Haslinger et al. 2001; Kwak 
et al. 2012) whilst performing a variety of motor tasks in the scanner.  A serious 
concern in the motor activation in PD literature is the heterogeneity of findings. For 
example, the pre-SMA has been consistently observed in fMRI studies of motor 
control as significantly different from controls. However, whether the difference was 
an increase or decrease of BOLD signal in PD patients varies across studies. 
Certainly, one issue for these discrepancies could be the variety of motor tasks 
implemented in the scanner i.e. finger tapping vs. ankle movement. An alternative 
approach for assessing motor networks in PD could be the investigation of brain 
activity in the absence of a task. By doing so, performance related confounds are 
eliminated. In the healthy brain, motor networks are required to maintain a resting 
state equilibrium in order to perform future motor tasks (Bressler & Kelso 2001), thus 
the resting brain or the intrinsic activity of the brain may be disrupted in 
neurodegenerative disease and in turn, disrupt the active motor network. Rs-fMRI 
studies have also been blighted by discrepant findings that may well be due to 
differences in preprocessing or statistical analysis of the data.  
The majority of these studies have consisted of a cross-sectional design that is 
vulnerable to greater inter-individual variability in regard to BOLD signal. Thus, 
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conducting within-subject longitudinal studies needs to be exploited to robustly assess 
activation changes in motor networks across PD progression.  Furthermore, it is 
believed that brain regions involved in motor control do not act in isolation. 
Therefore, investigating functional connectivity changes over time is also crucial to 
motor network alterations in PD. 
Here, a subset (n = 29) of PD patients from Chapter 3 underwent a second scanning 
session on average 19.8 months following the baseline scan. The fMRI motor 
paradigm and rs-fMRI were repeated in all subjects to investigate within subject 
changes in both the active and resting motor network over time as a function of PD 
progression. 
 
2. Aims 
The aims of this chapter were to: 
- Characterise regional and connectivity alterations of the active and resting 
neural motor network in PD patients over time. 
- Investigate whether neural motor network alterations over time significantly 
correlated with clinical parameters.    
 
 
3. Hypotheses 
The hypotheses of this chapter were: 
- PD patients will show a decline in behavioural motor performance over time.  
-  Regional decreases of BOLD signal identified in Chapter 3 will be confirmed 
longitudinally. 
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- Functional connectivity between regions will be altered as a function of 
disease progression.  
 
4. Subjects and methods 
4.1 Patients 
Twenty-nine PD patients included in Chapter 3 returned for the follow-up scanning 
session, which was an average 19.8 months (SD = 3.8 months) after the baseline scan 
(Table 7). PD patients demonstrated significantly increased disease severity as 
measured by the UPDRS-III (p<0.0001) and had significantly higher LED (p<0.001). 
All PD patients still fulfilled the UK brain bank criteria for PD at follow-up (Hughes 
et al. 1992). The clinical battery included H&Y staging, UPDRS-III, MMSE and 
calculation of LED. 
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Table 7. Patient characteristics in the longitudinal study 
 Baseline Follow-up (mean ± 
SD; 19.8m ± 
3.8m) 
P value* 
N 29 29 - 
Male:Female 22:7 22:7 - 
Age (mean±SD) 55.5 ± 7.44 57.2 ± 7.37 - 
Disease duration 
(years ± SD) 
4.19 ± 2.24  5.5 ± 2.3 - 
UPDRS-III  OFF 
(mean±SD) 
27.38 ± 9.6 35.7 ± 12.1 P < 0.0001 
UPDRS-III OFF % 
change over time 
(mean±SD; range) 
37.83% ± 43.71; 0 – 152.63% 
LED (mean±SD) 464.53 ± 265.6 564 ± 286.9 P < 0.001 
MMSE (mean±SD) 29.7 ± 0.6 29.7 ± 0.6 ns 
Patient characteristics showing that UPDRS-III OFF and LED significantly increased over time. 
*paired t test; m= months; SD = standard deviation; UPDRS-III = Unified Parkinson’s Disease 
Rating Scale Part III; LED = Levodopa equivalent dose; MMSE = mini mental state examination. 
 
 
4.2  Scanning procedures 
Scanning procedures were as previously described (Chapter 3. In brief, PD patients 
underwent a T1 structural scan, two runs of the fMRI motor paradigm interjected with 
a single rs-fMRI scan. All scans took place on a morning session (between 10.00 and 
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13.00 h) in the practically defined ‘OFF’ condition following withdrawal of 
medication between 18 h and 36 h pre-scan. 
4.3  Behavioural motor data 
Measures of motor execution and motor amplitude as earlier described (Chapter 3) 
were collected during the fMRI motor paradigm. These data were used to for 
statistical comparison against the baseline performances.  
 
4.4 Image analysis 
All scans underwent rigorous quality control and were analysed as described in 
Chapter 3. In brief, fMRI motor task data were analysed using SPM version 8 
following preprocessing steps of realignment, motion and slice time correction, 
coregistration, nomalisation and smoothing.  
Rs-fMRI data analyses were completed using MELODIC in FSL with preprocessing 
steps: motion corrected, skull stripping, grandmean scaling, temporal filtering (0.01-
0.1 Hz), normalization and registration. 
 
4.5  Statistical analysis 
Following pre-processing of image data, voxel-based comparisons between baseline 
and follow-up visits of the fMRI motor paradigm were performed using paired t tests 
in SPM8. The GLM included contrasts for each movement vs no movement condition 
and included motion parameters. These contrasts were used for second level, group 
analysis. An initial statistical threshold of p<0.001 and a voxel threshold of 20 voxels 
were used for the ROI analysis. Anatomical ROIs were taken from the WFUPickatlas 
using a priori hypotheses based on findings form the baseline study (Chapter 2). Peak 
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voxel activation was determined at the group level for two groups according to scan 
visit.  
Functional connectivity analyses for both motor and rs-fMRI were completed in FSL 
as described in Chapter 3. In brief, regional timeseries were extracted and Pearson r 
correlation coefficient maps were generated. Motor task fMRI data were converted to 
z maps due to variance in the data.   
Statistical analyses of the motor behavioural data were completed using SPSS for 
Macintosh. Paired t tests were used for statistical comparisons between scan visits.  
 
5. Results 
5.1 Clinical changes 
Over an average 19.8 months, PD patients presented a decline in motor function 
evidenced by significantly higher levels of disease disability as measured by UPDRS-
III and a significantly increased intake of LED (Table 7). There was no apparent 
cognitive decline as measured by the MMSE. 
 
5.2 Behavioural analysis 
PD patients demonstrated a significant decline in both motor execution (p = 0.002) 
and amplitude (p= 0.0001) whilst performing the fMRI motor task over time (Figures 
10 and 11).  
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Figure 10. Motor execution performance in PD patients across visits (mean Interval 
19.8 months) 
  
Performance of motor execution over time showing that patients had significantly declined in visit 2 
versus visit 1 with standard deviation. Motor Execution = mean reaction time (ms) for subject to move 
the joystick from its starting position to its peak movement (furthest point form initial starting position). 
** = p < 0.002, paired t-test. 
 
Figure 11. Motor amplitude performance in PD patients across visits (mean Interval 
19.8 months) 
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Performance of motor amplitude over time showing that patients had significantly declined in visit 2 
versus visit 1 with standard deviation. Motor Amplitude = mean distance from initial starting point to 
furthest point indicating completion of movement. Measurements taken from ‘movement’ conditions 
only and averaged across all trials in both runs. *** = p < 0.0001, paired t-test.  
 
5.3  fMRI motor task: ROI analysis 
ROI analysis confirmed the whole brain analysis results. Further ROIs were placed 
bilaterally in the pallidum due to a priori hypothesis of the potential role of the 
pallidum in a functional network of motor execution in PD. All ROIs showed a 
significant reduction of BOLD signal over time (p<0.01) (Table 8; Figure 12). 
 
Table 8. Significant ROIs with BOLD signal reduction over time in PD patients. 
Region MNI Z score 
Caudate  -10, 20, -6 3.03** 
DLPFC -54, 26, 22 3.51** 
Pre-motor   -44, 2, 40 3.52** 
M1  -28, -28, 72 3.42** 
Somatosensory  -14, -36, 76 3.19** 
SMA  -16, -12, 64 3.02** 
Pallidum  -22, -12, 4 2.52* 
Putamen  -24, -12, 4 2.63* 
Thalamus  -14, -20, 10 1.89* 
BOLD signal reductions in motor ROIs in PD patients from visit 1 to visit 2. Shows significant BOLD 
signal reduction in all key motor related regions. All cluster corrected, thresholded at 20 voxels; 
	   102	  
*p<0.05, **p<0.01; MNI Montreal Neurological Institute coordinate space; M1 = primary motor 
area; DLPFC = dorsolateral prefrontal cortex; SMA = supplementary motor area. 
 
Figure 12.  Regional BOLD signal reduction at follow-up vs. baseline 
  
Transverse sections of statistical parametric maps showing significant BOLD signal decreases (blue - 
white) associated with movement versus rest in PD patients over time.  A = bilateral M1**; B = 
bilateral somatosensory cortex**; C = bilateral premotor area**; D = bilateral SMA**; E = bilateral 
caudate**; F = bilateral putamen**; G = bilateral pallidum**; G = right thalamus*; I = bilateral 
DLPFC**. Colour bar indicates z scores. * = p < 0.05; ** = p < 0.01, cluster corrected, thresholded 
at 20 voxels. 
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5.4 fMRI motor task: time series regional analysis 
The mean time series (mean run1 + mean run2) for each ROI was extracted to 
evaluate whether observed reduction in the voxel-based analysis was due to a 
significant reduction only or whether a deactivation occurred. The time series analysis 
confirmed the voxel-based analysis but provided further information regarding the 
caudate which demonstrated a deactivation (Figure 13). 
 
Figure 13. ROI extracted time series for movement vs. no-movement condition in PD 
patients.  
 
 
Extracted time series z scores for motor network ROIs. Shows all ROIs significantly declined in 
activation over time with caudate demonstrating a hypoactivation over time. DLPFC = dorsolateral 
prefrontal cortex, SMA = supplementary motor area, M1 = primary motor cortex. * = p <0.05; ** = p 
< 0.01. Paired t tests. 
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5.5 fMRI motor task: functional connectivity 
Regional functional connectivity in the motor network of PD patients altered over 
time. There was a generalised increase of connectivity within DLPFC and putamen 
connections and a decrease of caudate connectivity (Figure 14). Significant reductions 
of connectivity between caudate and cortical regions: M1, premotor area and SMA 
were detected as a consequence of disease progression (p < 0.05). No other decreases 
and no increases of connectivity were found to be significant.  
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Figure 14.  Active functional connectivity changes over time in PD patients 
  
Functional connectivity analyses. Fisher z-transformed correlation co-efficients for the functional 
connectivity between motor related regions during the fMRI motor task. Showing significant decreases 
between, caudate, premotor and M1 and SMA from visit 1 to visit 2. Groups according to disease 
burden (DB). Red = increased connectivity as disease burden increases; blue = decreased connectivity 
as disease burden increases DLPFC = dorsolateral prefrontal cortex; M1 = primary motor area; SMA 
= supplementary motor area. Changes in correlation r values over time indicated by colour scale: red 
= increased correlation over time; blue = decreased correlation over time. Significant changes in 
functional connectivity from baseline to follow-up are indicated by a black asterisk *= p < 0.05. 
. Significant correlation indicated by bold asterisk. Pearson r correlation, p < 0.05 (corrected for 
multiple comparisons, bonferroni). 
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5.6  Rs-fMRI: functional connectivity 
Regional functional connectivity in the resting motor network of PD patients altered 
over time. There was evidence of decreased connectivity within the network between 
putamen with M1 (p = 0.5) and somatosensory cortex (p = 0.05) (Figure 15). 
Interestingly, the direction of changes was generally in opposition to findings within 
the active motor network.  
 
Figure 15. Resting functional connectivity changes over time in PD patients 
  
Functional connectivity analyses. Pearson r correlation maps for the functional connectivity between 
motor related regions during the rs-fMRI scan. Showing significant decreases in connectivity between 
putamen, M1 and somatosensory area between visit 1 to visi 2. Groups according to disease burden 
(DB). Red = increased connectivity as disease burden increases; blue = decreased connectivity as 
disease burden increases DLPFC = dorsolateral prefrontal cortex; M1 = primary motor area; SMA = 
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supplementary motor area. Changes in correlation r values over time indicated by colour scale: red = 
increased correlation over time; blue = decreased correlation over time. Significant changes in 
functional connectivity from baseline to follow-up are indicated by a black asterisk *= p < 0.05. 
. Significant correlation indicated by bold asterisk. Pearson r correlation, p < 0.05.  
 
 
6. Discussion 
This study presents for the first time a combined assessment of both the active and 
resting motor network in PD over time. Twenty-nine PD patients undertook two 
scanning sessions consisting of fMRI a motor paradigm and rs-fMRI on average 19.8 
months apart. The current cohort returning for the follow-up scan had significantly 
declined in motor function as measured by UPDRS-III and were receiving 
significantly more DA-ergic medication, which is a sensible clinical assumption to 
make and enables assessment of neural network alterations in relation to disease 
progression. Behavioural in-scanner data reveal a significant decline in motor 
execution and motor amplitude performance in the PD patients over time. All PD 
patients were able to complete the task efficiently but were slower and completed 
more restricted movements at follow-up compared to baseline. These findings are 
clinically in line with disease progression averaging ~38% increase of UPDRS-III 
scores over time. 
Investigation of regional BOLD signal change over time during the fMRI motor task 
across time revealed significant reductions in key cortical and subcortical areas 
involved in the motor network (striatum, thalamus, motor cortices, DLPFC, 
somatosensory cortex). These findings were corroborated following extraction of 
regional time series data and no significant regional increases in BOLD signal were 
detected. Indeed, evaluation of time series data reveals that whilst all regions had a 
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reduction of activity, the caudate demonstrated a deactivation. The known 
connections between caudate and prefrontal areas and its role in goal directed 
movements, could explain the deactivation. The motor task completed by PD patients 
in the scanner required patients to view an external cue and purposefully initiate and 
complete a movement in a specific direction, thus possessed goal directed behavior. 
The greater difficulty experienced by patients to perform these movements as 
observed by the significant decline in behavioural performance appears to be reflected 
in the deactivation of a key region critical in both motor control and higher order 
executive functioning enabling goal directed behaviour. Furthermore, interrogation of 
clinical correlations reveals a significant negative correlation between percentage 
change of UPDRS-III with BOLD signal change in premotor, M1, SMA and 
somatosensory cortices, i.e. the greater decline in motor function correlates with a 
greater loss of BOLD signal over time. To date, the vast majority of fMRI studies of 
motor control in PD have been cross-sectional, change of amplitude studies. As 
previously mentioned, results have been varied and could be a reflection of 
heterogeneous samples, tasks implemented or an indication that multimodal imaging 
applications and/or analysis methods are required to fully elucidate the mechanisms 
underlying neural motor networks in PD. Prior to the current study, only one fMRI 
study has attempted to assess neural alteration longitudinally (Sen et al. 2010). Sen et 
al., investigated CTC motor circuitry in 5 PD patients over 2 years compared against 
5 control subjects. It was reported that PD patients had an increased recruitment of 
CTC circuits during a motor task using the most clinically affected hand, that is, the 
side which was most clinically affected over 2 years required increased activity in 
CTC circuits to complete the tasks compared to the less clinically affected side which 
showed no changes compared to control subjects. Sen et al., concluded that this 
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evidenced compensatory mechanisms over time in CTC due to dysfunction in the 
striato-thalamo-cortical circuits. Although providing the first attempt of to assess 
neural motor network alterations as a function of disease progression, this study is 
limited through its small sample size and its inability to be certain the patient cohort 
had adequately withdrawn from medication. It is generally accepted that scanning PD 
patients following 12 hours post medication withdrawal (Quinn et al. 1996) is 
sufficient for patients to be in the practically defined ‘OFF’ medication state. The 
current study exceeding this by withdrawing from medication at least 18 hours 
previously (36 hours if receiving a prolonged-released form), we are confident that 
potential medication effects would be eliminated from effects on BOLD signal. 
Furthermore, the current sample size is larger than Sen et al., (n = 29 vs. 5) and 
covered a wider range of disease severity (UPDRS-III mean at baseline = 27 vs 4).  
The concept of connectivity between regions has provided a theoretical framework for 
identification of brain network interaction thus providing an additional source of 
information for identifying regional changes in magnitude of brain activity.  PD 
induced modifications of brain networks have been explored in multiple studies 
(Rowe et al. 2002; Palmer et al. 2009). To date, only one study has investigated this in 
relation to self-initiated movements in PD (Wu et al. 2010). A reduced connectivity 
between striatal-cortical interactions and an increased connectivity between cortico-
cerebellar structures was reported. Patients were performing the motor task at the 
same level as the healthy volunteers; therefore the authors hypothesised the increased 
connectivity to be a compensatory mechanism resulting from the striatal-cortico 
dysfunction. The current study demonstrates both increases and decreases of 
connectivity in the active motor network suggestive of a dynamic neural network, 
which may reflect compensatory mechanism initiation with significant decreases of 
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connectivity between caudate and SMA, M1 and premotor area which corroborate 
BOLD signal decreases in the regional amplitude analysis. These findings are in line 
with the caudate hypoactivation observed in the current regional amplitude analysis 
and highlight the importance of including multiple analysis techniques to further 
interrogate neural changes in the context of a network, as it is clear that brain regions 
do not act in isolation.  
Rs-fMRI has shown promise as a technique for development of a neurodegenerative 
biomarker. A basal ganglia resting network has been previously identified as 
possessing the ability to differentiate PD from healthy controls (Szewczyk-
Krolikowski et al. 2014) and recently the same network has provided evidence that 
resting state basal ganglia dysfunctions are specific to PD and not representative of a 
generalised neurodegenerative process (Rolinski et al. 2015). Despite the basal 
ganglia clearly playing a critical role in PD pathophysiology, when considering a 
relatively novel imaging modality (rs-fMRI), it is important to understand its 
dynamics on a larger scale in relation to the entire brain. The current study attempted 
to investigate resting connectivity of key motor regions, identified during the active 
motor task, thus, the resting motor network. Analyses revealed significant decreases 
in putaminal connectivity with M1 and somatosensory cortex and a trend toward 
increased connectivity of caudate with cortical regions that could be an indication of 
intrinsic brain networks attempting to compensate for the declining active motor 
network from caudate to cortical regions. However, it must be noted that the observed 
changes in the caudate were not significant and may be the result of spurious 
correlations in the rs-fMRI data due to the limited de-noising that was applied to the 
current dataset. Future studies should apply robust de-noising approached to the data 
prior to model-based analyses in rs-fMRI data. Previous rs-fMRI studies specifically 
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identifying motor networks through activation of motor networks in PD are lacking. 
Wu et al., (Wu, Long, et al. 2011) identified in 18 PD patients compared to 18 control 
subjects, altered connectivity between pre-SMA and M1 (increased), and between 
pre-SMA and putamen, insula, premotor area and IPL (decreased). The authors 
concluded that the disrupted connections represented a lack of readiness for 
movement and suggest that their findings are more pertinent in light of motor 
initiation rather than motor execution. The only study to report longitudinal changes 
of the resting motor network used whole brain functional ALFF (fALFF) over 2 years 
in 17 PD patients compared to 20 control subjects (Wang et al. 2015). The authors 
report increased ALFF in the right temporal and occipital gyri over 2 years and 
decreased ALFF in the cerebellum, striatum, thalamus, superior and inferior parietal 
lobule, precentral and postcentral gyri. These results are interesting, as they do not 
include the potentially expected primary or secondary motor areas.  
The current study found decreased resting connectivity between putamen with M1 
and somatosensory cortex. The putamen is located in a key position in the basal 
ganglia circuit which is responsible for the effective initiation and execution of 
movements. The significant decrease of putaminal-M1 connectivity in our cohort over 
time fits in with basal ganglia models of PD an well as previous studies reporting 
similar less functional synchronization of the putamen in PD at cross-sectional level 
(Wu & Hallett 2005). 
It is clear that the body of work currently existing for regional amplitude alterations 
and functional connectivity in PD is complicated to interpret and certainly requires 
further studies to define network interactions and effects of disease on these 
interactions. Our findings add to the general view that the PD pathological process 
interrupts regional functional connectivity as seen by the loss of significant functional 
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connectivity between caudate and cortical motor regions in the active state, the trend 
toward regaining connectivity in the resting state and significant loss of connectivity 
between putamen and cortical regions in the resting state. This study serves to 
increase sensitivity compared to previous studies due to the longitudinal design and to 
highlight the importance of multimodal imaging and multiple analysis approaches to a 
data set.  The current study is limited by the lack of whole brain analyses and/or 
region of no interest to control for potential nonspecific changes over time.  Future 
studies should consider this.  
Currently, a wide range of methodological approaches for functional connectivity 
analysis exist which are yet to be tested in large cohorts or across a wide variety of 
disease stages to allow clear identification of the optimal approach. Thus, further 
validation of these methodologies and the current findings of active and resting motor 
networks in PD are required. 
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CHAPTER 5: LONGITUDINAL CHANGES IN DIFFUSION OVER 
TIME 
1. Introduction 
DTI provides a non-invasive in vivo method to estimate diffusion metrics. 
Neurodegenerative cell loss results in a loss of diffusion barriers and orientational 
dependence, thus DTI is a useful method to assess neurodegenerative processes. 
Multiple DTI studies have attempted to clarify its use as a biomarker for PD 
(Yoshikawa et al. 2004; Péran et al. 2010; Rolheiser et al. 2011; Vaillancourt et al. 
2009). To date, no study has systematically assessed multiple groups of PD across 
various disease stages or followed patients over time. However, there have been 
attempts to identify an index of diffusion that correlates with disease severity. Chan et 
al., (2007) reported an inverse correlation of nigral FA with disease severity and no 
significant differences of FA in any other basal ganglia structure (Chan et al. 2007). 
Further FA alterations have been reported in established motor circuit regions: SN, 
putamen, thalamus, M1, premotor area and SMA and somatosensory areas that 
significantly correlated with disease severity (Zhan et al. 2012). Conversely, further 
reports did not find a correlation between disease severity and diffusion indices 
(Vaillancourt et al. 2009; Menke et al. 2010; Du et al. 2011), thus leading to a debate 
regarding the potential for DTI to be a reliable technique for tracking disease 
progression or its use as a biomarker. This debate is solidified in two recent 
systematic reviews (Cochrane & Ebmeier 2013; Schwarz et al. 2013) with opposing 
conclusions.  
Attempts to characterise extra-nigral diffusion indices have also resulted in variable 
findings. FA reductions in corpus callosum genu and superior longitudinal fasciculus 
and MD increases in the same areas have been reported in early stage medicated PD 
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patients (Gattellaro et al. 2009). FA reduction in gyrus rectus has been reported 
(Ibarretxe-bilbao et al. 2009) as well as FA reductions and MD increases in motor and 
frontal cortices (Zhan et al. 2012) and track density indices were found to be 
increased in regions associated with the motor circuit (Ziegler et al. 2013). However, 
other studies have failed to find significant differences of extra-nigral FA or ADC in 
the striatum and thalamus (Chan et al. 2007), or FA and MD in corpus callosum and 
cingulum (Wiltshire et al. 2010). Kim et al. (2013) employed TBSS and VBA and 
report no significant differences of FA in PD patients compared with healthy controls 
(Kim et al. 2013). Increased MD was reported in striatum, pallidum, thalamus, 
cingulum and fornix.  Zhan et al., (2011) used VBA to identify a reduction of FA in 
the cerebellum and increased MD in the orbital-frontal cortex and inferior temporal 
gyrus (Zhan et al. 2012).   
DTI offers a promising technique to understand changes in brain microstructure in 
neurodegenerative disease and much is known about nigral FA in PD, however it is 
not clear how diffusion indices progress over time and their relevance to the 
progression of clinical symptomatology in PD. Here, we have undertaken a 
longitudinal DTI study in 18 PD patients followed up over 19.8 months. This study 
aims to assess how FA and MD in the substantia nigra and striatum change over time 
as a consequence of early disease progression using a manual delineation ROI 
approach and VBA. 
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2. Aims 
- To examine nigro-striatal diffusion microstructure in PD patients over time. 
- To assess whether alteration in nigro-striatal microstructure correlate with 
clinical symptomatology.   
 
3. Hypotheses 
It is hypothesised that measures of diffusion (fractional anisotropy, FA and mean 
diffusivity, MD) will be significantly altered over time and that motor control in PD 
patients will be significantly correlated with diffusion measures.   
 
4. Subjects and Methods 
4.1 Patients 
Eighteen non-demented patients with idiopathic PD (Hughes et al. 1992) were studied 
with a longitudinal two-scan DTI protocol (mean: 19.5m between scans; standard 
deviation, SD: 3m). These 18 patients were selected from a possible 43 patients. 
Twenty-five patients were excluded due to poor data quality (high signal dropout in 
frontal sinuses area and motion artefacts). The clinical assessment battery included 
the motor part (Part III) of Unified Parkinson’s Disease Rating Scale (UPDRS), Mini-
Mental Sate Examination (MMSE) and calculation of daily L-dopa-Equivalent-Dose 
(LED) (Table 9). A larger sample size would be desirable, however, using a 
longitudinal design will increase power.  
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Table 9. Patient characteristics in the DTI study. 
 PD 
Baseline 
PD Follow-
up 
(When?) 
P value 
Number of Subjects  18 18 - 
Age (years ± SD) 56.8 ± 6.8 58.3 ± 6.8 - 
Sex 12M/6F 12M/6F - 
Disease Duration (years ± SD) 3.9 ± 2.2 5.5 ± 2.2 - 
UPDRS OFF motor (Part III) 
score (mean ± SD) 
26.2 ± 9.2 34.6 ± 12.5 P = 0.0003 
% change in UPDRS OFF motor 
score (mean ± SD; range) 
28.6 ± 24.9%; 0 – 80% P = 0.0002 
MMSE (mean ± SD) 29.6 ± 0.6 29.7 ± 0.6 P = 0.4 
Daily LEDTOTAL (mg ± SD) 442.4 ± 
245.6 
564.0 ± 
286.9 
P = 0.008 
Patient characteristics from visit 1 to visit 2 showing significant increases in UPDRS-III OFF scores, 
and LED. * Paired t test; m= months; SD = standard deviation; UPDRS-III = Unified Parkinson’s 
Disease Rating Scale Part III; LED = Levodopa equivalent dose; MMSE = mini mental state 
examination. 
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4.2 Scanning procedure 
Subjects were scanned on two separate mornings (between 10.00 and 13.00 h) on 
average, 19.5 months apart.  All subjects were scanned in the practically defined 
‘OFF’ condition having withdrawn from medication at least 18 h previously (or 36 h 
if receiving a prolonged released form). Image acquisition for DTI was conducted as 
per the descriptions detailed in Chapter 2. 
 
4.3 ROI delineation 
Caudate and putamen were manually drawn on the FA map using the co-registered 
T1-weighted image of the selected individual for anatomical guidance. SN was drawn 
manually on the co-registered B0 (T2) image for guidance (Figure 16). 
 
4.4 Image analysis 
All data were analysed with two approaches: manual ROI analysis and VBA. 
ROI analysis was conducted using ExploreDTI and TrackVis. Data were converted 
from DICOM (Digital Imaging and Communications in Medicine) to NifTI 
(Neuroimaging Informatics Technology Initiative) format. In ExploreDTI, bvec and 
bval files were generated and converted to B-matrix text files (128 x 128 x 70). 
DTI.mat files with the scanner parameters and b-matrix information were created 
which output the MD, FA maps for each subject. Eddy-current motion correction was 
applied to the data. ExploreDTI data were converted to TrackVis data via a code 
executed in Matlab (NBL_ExpDTi2TrakV (0, ‘T’,2,[])). MD and FA maps were then 
visualized in TrackVis to allow delineation of our ROIs. Our a priori hypothesis 
dictated the putamen, caudate nucleus and SN as ROIs. Two experienced raters (C. 
Loane and another imaging scientist) drew all ROIs manually on both the MD and FA 
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maps for each subject. Data was re-coded to ensure both raters were blind to the 
subject and visit information of each scan. The interrater reliability  
was Kappa = 0.68 (p <.0.001), 95% CI (0.504, 0.848).  
 
VBA was used to compare MD and FA maps between groups. All FA and MD maps 
were aligned using FMRIB’s Nonlinear Registration Tool (FNIRT) with a threshold 
of 0.2 to exclude peripheral tracts with significant inter-subject variability and/or 
partial volume effects with GM. Following spatial normalization, the FA and MD 
maps were smoothed with 8mm isotropic Gaussian kernel to reduce noise and correct 
misalignments.  
 
4.5 Statistical Analysis 
Statistical analyses for FA/MD clinical correlates and clinical and demographic data 
were performed using SPSS (version 16, SPSS Inc) for Macintosh. Comparisons 
within groups were performed using paired t-tests.  
Statistical comparisons for VBA were performed using statistical parametric mapping 
(SPM12, http://www.fil.ion.ucl.ac.uk/spm) and paired t tests between baseline and 
follow-up visits. An uncorrected p<0.001 at voxel level for multiple comparisons and 
a cluster extent of 20 voxels was used.  
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Figure 16.  Substantia Nigra ROI placement.  
 
 
 
 
 
 
Example of a DTI scan of a patient and substantia nigra ROI placement. ROIs defined 
by two scientists blinded by visit number and patient ID. The interrater reliability  
was Kappa = 0.68 (p <.0.001), 95% CI (0.504, 0.848).  
  
 
5. Results 
5.1 Clinical changes 
UPDRS-III scores had significantly declined over 19.8 months (mean change of 28.6 
% on UPDRS-III; p=0.0003) and LED significantly increased (average increase of 
121.6mg; p=0.0002). MMSE remained unchanged and within normal limits over time 
indicating no decline in cognitive functioning. No other significant health concerns 
were reported by the subjects at follow-up. 
 
 
5.2 ROI Analysis 
Regional MD values were stable in caudate (1.1 vs 1.1; p=0.4) and putamen (0.7 vs 
0.7; p=0.2) but significantly increased in SN (0.3 vs 0.9; p=0.01) from baseline to 
follow-up. Similarly, FA values remained stable at follow up in caudate (0.188 vs 
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0.183; p = 0.3) and putamen (0.22 vs 0.22; p = 0.2) but significantly reduced in SN 
(0.48 vs 0.45; p=0.008) (Table 10, Figure 17). 
 
Table 10. Diffusion indices from ROI analysis  
 Baseline Follow-Up P value 
Caudate Putamen SN Caudate Putamen SN  
FA ± 
SD 
0.18831 
± 0.0519 
0.2221 ± 
0.028 
0.4839 ± 
0.048 
0.1833 ± 
0.0481 
0.2254 ± 
0.0281 
0.4561 ± 
0.0451** 
**0.008a 
MD ± 
SD 
1.1 ± 0.3 0.76 ± 
0.1 
0.83 ± 
0.2 
1.1 ± 0.3 0.75 ± 
0.04 
0.93 ± 
0.13* 
*0.014a 
Diffusion indices over time form visit 1 to visit 2 in caudate, putamen and SN. Showing significant 
decline in FA and MD in the SN. apaired t test; SD = standard deviation; FA = fractional anisotropy; 
MD = mean diffusivity (displayed 10(-3); SN = substantia nigra. Values are mean from rater 1 and 
rater2 . 
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Figure 17. Alteration of nigral diffusion indices in PD patients over time. 
  
Alteration of nigral diffusion in PD patients from visit 1 to visit 2 showing significant increases of 
nigral FA and significant decreases of nigral MD. A : Mean nigral MD values for PD patients at 
baseline and follow-up. ** = p< 0.01, paired t test. B:  Mean nigral  FA values for PD patients at 
baseline and follow-up. ** = p< 0.01, paired t test. MD = mean diffusivity; FA = fractional 
anisotropy. 
 
5.3 Clinical Correlations 
Nigral MD values at follow-up significantly correlated with % increase of UPDRS-III 
from baseline to follow-up (r = 0.39, p = 0.05) (Figure 18).  No significant correlation 
was found with caudate or putamen MD. 
Nigral, caudate or putamen FA values at follow-up did not significantly correlate with 
increase of UPDRS-III.  
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Figure 18. Correlation between nigral MD and % change of UPDRS-III at follow-up. 
 
 
Significant correlation for % change nigral MD with % change of UPDRS-III change from visit 1 to 
visit 2 in PD patients. r = 0.39, p = 0.05; UPDRS = Unified Parkinson Disease Rating Scale, Part III; 
MD = mean diffusivity. 
 
5.4 VBA 
There were significant FA reductions within left caudate, bilateral putamen and right 
SN in the PD patients at follow-up compared to baseline. Significant increases in MD 
were detected in left caudate and left putamen but not in SN  (Table 11, Figure 19). 
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Table 11. VBA of FA and MD over time in PD patients 
Diffusion Index Region MNI Z score P value c 
FAa Caudate -16, 18, 5 4.33 0.001 
Putamen 21, 9, 3 2.73 0.01 
SN 7, -12, -10 2.35 0.05 
MDb Caudate 6, 8, 2 1.79 0.05 
Putamen -28, -6, 14 2.21 0.05 
SN - - ns 
 
VBA results showing significant changes in FA within the caudate, putamen and SN and significant 
changes in MD within caudate and putamen.  a thresholded at 20 voxels, b thresholded at 10 voxels c 
paired t test; SD = standard deviation; FA = fractional anisotropy; MD = mean diffusivity; SN = 
substantia nigra. 
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Figure 19. Significant regional alterations of diffusion indices in PD patients. 
 
Significant changes detected by VBA in FA and MD in the PD patients from visit 1 to visit 2. A = 
Transverse sections of parametric maps showing significant FA decreases (blue-white) in PD patients 
over time: left caudate***; bilateral putamen**; right substantia nigra*. B = Transverse sections of 
parametric maps showing significant MD increases (red-yellow) in PD patients over time: left 
caudate*; left putamen*. Colour bar indicates z scores. * = p < 0.05; ** = p < 0.01; *** = p < 0.001, 
cluster corrected, thresholded at 20 voxels for FA and 10 voxels for MD. 
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6. Discussion 
Using manual ROI analysis and VBA microstructural changes of subcortical grey 
matter in patients with PD over time were investigated. Here we have demonstrated 
alterations of both nigral FA and MD with the latter correlating with percentage 
change of UDPRS-III scores indicating increased disease severity. With VBA, 
significant regional decreases in FA within the SN and striatum as well as significant 
increases of MD within the striatum were demonstrated 
The current cohort can be considered relatively mild regarding disease severity (mean 
disease duration and UPDRS-III at baseline: 3.9 years, 26.2 and at follow-up: 5.5 
years, 34.6), which is in line with most previous cohorts studied with DTI. As such, 
we consider our results as a novel extension of previous reports of nigral FA and MD 
alterations through our longitudinal study design, which considers disease 
progression. Identifying the nature of early progression in PD is vital for the 
generation of suitable imaging biomarkers. 
Our findings of striatal alterations of diffusion are in line with concepts demonstrated 
in previous PET reports (Playford et al. 1992) and are likely related to the progressive 
degeneration of nigrostriatal DA neurons. Previous DTI reports of striatal diffusion in 
PD are less consistent. Microstructural degradation in the striatum has been reported, 
particularly the increase of MD (Péran et al. 2010; Kim et al. 2013) in PD patients. 
Conversely, other studies failed to find alterations within the striatum and report white 
matter alterations in fibre bundles such as the genu of the corpus callosum and 
superior longitudinal fasciculus (Gattellaro et al. 2009)and frontal areas (Karagulle 
Kendi et al. 2008). 
Nigral diffusion alterations have been investigated in slightly more detail and 
although there are conflicting reports, it appears that a decrease of FA and increase of 
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MD is the prevailing conclusion of microstructural alterations in PD. Decreases of 
nigral FA have been demonstrated in several studies (Vaillancourt et al. 2009; 
Rolheiser et al. 2011; Chan et al. 2007). To date only two studies have identified a 
significant correlation of nigral FA and disease severity (Chan et al. 2007; Zhan et al. 
2012). Here, we also failed to find a significant correlation with our nigral FA 
changes over time. This is in line with previous lack of correlation (Vaillancourt et al. 
2009; Menke et al. 2010; Du et al. 2011) and may indicate that nigral FA alterations 
do not possess the predictive power to track disease progression in PD. A recent meta-
analysis highlights the problematic nature of using nigral FA as a predictor for PD 
pathology stating a high degree of variability in the published reports of nigral FA 
changes (Schwarz et al. 2013). The same meta-analysis reported a case control study 
that failed to identify nigral FA changes but did report significant nigral MD 
increases. These increases were detectable only following an ROI analysis and not 
with VBA. Similarly, we were unable to detect nigral MD alterations with VBA. The 
differences between differing analysis methods are not clear however, it seems that 
VBA is less sensitive at detecting alterations of microstructural indices with previous 
studies also failing to replicate, or require liberal thresholds to confirm ROI or TBSS 
findings with VBA (Rae et al. 2012). Furthermore, due to variability in normalisation 
procedures for FA and MD maps, partial volume effects in the SN (sue to its small 
size) and striatum (due to the internal capsule) could lead to inconsistent findings. 
Here, we detected differences only with statistically thresholds and not more stringent 
corrections, thus VBA results should be treated with caution. 
However, considering the importance of subcortical structures in PD, it is rational to 
omit TBSS, which is more suitable to the assessment of white matter regions and fibre 
bundles. Nonetheless, methodological differences in study planning, scan acquisition, 
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analysis methods need to be elucidated to ensure the variance of results of studies is 
reduced. Further inconsistencies may arise due to subject characteristics and small 
sample sizes.   
Unlike Schwarz et al., (2013), our nigral MD alterations were significantly correlated 
with percentage change of UPDRS-III over time. Previous studies generally report a 
marginal increase in MD but lack clinical correlates. It is known that MD can 
distinguish atypical parkinsonisms from PD (Blain et al. 2006; Schocke et al. 2002; 
Seppi et al. 2003) thus our finding indicates that nigral MD may suggest a 
microstructural change as a direct result of disease progression. This is the first report 
of a microstructural clinical correlate in PD. 
Our study used DTI to assess microstructural alterations in important subcortical areas 
in PD pathophysiology. We show that there are significant decreases of FA and 
increases of MD in the SN and striatum of relatively mild PD patients followed over 
time. Furthermore, we demonstrate a longitudinal clinical correlation of nigral MD 
and disease severity. These results provide for the first time, valuable information of 
the microstructural changes in the PD brain progressing over time. Further 
longitudinal studies are required to elucidate if our findings are consistent in larger 
sample sizes before a consensus on the use of DTI as an imaging biomarker in PD can 
be concluded.  
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CHAPTER 6: DISCUSSION 
Discussion and future directions 
1. Summary of Key Results 
PD is a common and debilitating neurodegenerative motor disease, which is known to 
result from the loss of DA-ergic neurons in the SN extending to the striatum and 
cortical regions as the disease progresses. Neuroimaging techniques have been 
applied to study the PD brain in relation to its motor deficits and have revealed 
relatively consistent findings of loss of amplitude activation in key motor related 
brain regions. However, it is not clear how the structural and functional connectivity 
between these regions are affected in the disease and if any compensatory 
mechanisms are in place, which would aid understanding of the disease processes, its 
effect on motor symptomatology or provide potential information for future 
interventional clinical trials or treatment guidance. Moreover, the study of PD over 
time has been lacking in the literature and limits understanding of how PD brain 
networks are affected as a function disease progression within subjects. Recent 
advances in neuroimaging techniques and methodological approaches have allowed 
scientists to investigate brain networks, not only during task-based activities but also 
at rest, thus assessing the intrinsic neural activity of an individual’s brain. Diffusion 
MRI has also permitted the assessment of brain microstructure previously not possible 
in the living brain.  
This body of research set out to investigate in a comprehensive, multimodal fashion, 
how motor networks are affected in PD both in relation of activated and resting 
connectivity (Chapters 3 and 4) as well as microstructure (Chapter 5). 
In Chapter 3, I conducted a cross-sectional study in four groups of PD patients 
divided according to disease burden (n = 19 each group). All patients underwent a 
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baseline scanning session involving a motor task-based fMRI and rs-fMRI. In-scanner 
behavioural data was also collected to assess motor execution and motor amplitude 
performances. One of the most important findings from Chapter 3 is that PD patients 
appear to possess compensatory mechanisms coming into effect while disease burden 
is still relatively low. Here, due to the collection of in-scanner behavioural data it 
appears that the compensatory mechanisms are more likely a function of motor 
reserve rather than a mechanism permitting enhanced motor functioning compared to 
patients with higher disease burdens. The increased amplitude activity and 
connectivity in both the task based and resting state motor networks indicate interplay 
or dependency between the intrinsic and activated neural networks. For instance, PD 
patients with low disease burdens appear to have generalised dysfunctional 
connectivity across both neural networks. As the disease burden increases, the 
activated motor network compensate for the increased difficulty in performing the 
task, which is only evident in the resting motor network later on.   
 
In Chapter 4, I conducted a longitudinal study of Chapter 3 in a sub-set of patients. 
Twenty-nine PD patients returned for a follow-up scanning session approximately 
19.8 months after baseline.  
Similarly, following PD patients over time indicates that the activated and resting 
motor network possess a dynamic in general opposition to each other. The exact 
underlying reason for this neural behaviour requires further investigation with larger 
sample sizes and a wider range of disease burdens followed over time. Nonetheless, 
these findings suggest dynamic neural systems in PD that appear to be making 
attempts to cope with the disease processes.  
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Finally, Chapter 5 presents longitudinal DTI data in eighteen PD patients. This study 
demonstrates significant alterations of nigral FA and MD measures over time and that 
nigral MD alteration is significantly correlated with % change of UPDRS-III.  This 
study did not detect any significant changes or clinical correlations with striatal 
diffusion measures suggesting that alterations within the SN may be a better indicator 
of disease processes in PD.  
 
2. Compensation mechanisms in PD motor networks 
It is known that the pathophysiological processes of PD lead to altered activations in 
motor related regions as measured by fMRI. Previous studies have typically used 
regional BOLD signal changes in PD compared to healthy controls or other non-PD 
patient groups, thus assessment of connectivity between motor related regions is 
lacking.  Furthermore, investigations of compensatory mechanisms or motor reserve 
capacity are lacking.  
The use of sequential motor tasks, which focus on motor planning and execution, 
appear to be particularly well suited for studying compensatory mechanism. Previous 
reports demonstrate a relative increases in premotor and parietal activity compared to 
controls using both fMRI (Sabatini et al. 2000) and PET techniques (Samuel et al. 
1997). These effects are generally interpreted as a compensatory effect to 
counterbalance the defective striato-frontal motor circuits. Motor deficits in PD 
patients appear to be improved when provided with external cues, thus it has been 
hypothesised that compensation effects can be observed following additional 
processing such as enhanced attention (Bloem et al. 2004). Compensatory mechanism 
may be interpreted at a neuronal level i.e. synaptic plasticity or systems level i.e. 
neural changes supporting a cognitive processes. Degeneracy is a term used to 
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describe compensation as occurring due to the ability of the elements of a circuit to 
reorganize in order to yield the same output (Edelman & Gally 2001). Degeneracy 
may provide an explanation why a profound number of DA-ergic neurons within the 
SN can be lost prior to the onset of symptoms. For instance, the PD brain may possess 
the ability to engage other brain regions within the motor network or in neighbouring 
regions thereby preserving the behavioural, functional output.  A report of increased 
connectivity between cingulate and premotor area in presymptomatic gene carriers of 
PD indicates that compensatory mechanisms may well be in place before 
symptomatic disease (Buhmann et al. 2005).  
The current thesis presents data, which indicates compensatory mechanisms are in 
place within both the active and resting motor network. The current data would also 
suggest that investigations of functional connectivity are particularly important to 
understand the dynamic alterations of the PD brain in response to pathophysiological 
processes. For instance, Chapter 4 reports the active motor network demonstrating 
only significant decreases in regional BOLD signal change over time, whereas the 
functional connectivity analysis demonstrates a trend towards reorganisation of 
connectivity relationships. It is currently unknown whether compensation occurs at a 
particular stage of PD i.e. once a certain number of DA-ergic a loss or whether it is a 
process initiating at early disease stage or even pre-symptomatically. The current 
thesis suggests both the active and resting motor networks are continuously 
undergoing dynamic alterations in an attempt to cope with disease processes. 
Defining the nature of compensation in PD motor networks may have a significant 
impact on therapeutic intervention. Indeed, in the case that the PD brain is employing 
mechanisms to overcome the pathophysiological processes and recruiting less 
affected, unaffected brain regions to maintain functional output then it would be 
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sensible to consider focusing therapeutic interventions not on the neurons that are lost 
but those which survive.  
The behavioural in-scanner data contained in the current thesis would point toward a 
situation whereby the PD brain is re-recruiting motor related regions to maintain 
motor performance.  
 
3. Studying networks longitudinally 
Although diagnosis of PD is primarily a clinical decision, neuroimaging is a 
promising tool for early disease detection and measure of disease progression. 
Advances in neuroimaging techniques have enabled detection of alterations in 
diffusion properties, anatomical and functional connectivity as well as neural-clinical 
correlates. However, literature to date has been lacking in relation to studying 
regional and networks changes over time, thus defining the effect disease processes 
have on neural mechanisms, either pathological or compensatory. Thus, current cross-
sectional findings, although opening the door to understanding intrinsic changes to 
neural networks in PD compared to the non-PD brain must be viewed with caution as 
without robust longitudinal studies, results may reflect pathological effects, 
compensatory mechanisms or indeed medication effects in the cases whereby subjects 
are scanned ON medication or failed to withdraw adequately.  
The results presented in this thesis confirm the importance of using a longitudinal 
design to investigate the dynamics of motor networks in PD as a function of disease 
progression. Both the active and resting motor networks in a sizable sample (n = 29) 
demonstrated that both increases and decreases across the motor network are altered 
over a period of approximately 19 months in a group of relatively mild–moderate PD 
patients. Using traditional regional amplitude measures of BOLD signal changes, only 
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significant decreases were detected across the motor network in the active state as a 
function of disease course. However, assessment of functional connectivity in both 
the active and resting networks indicates that compensatory mechanism may well be 
in place. It is likely that a larger period of time is required between follow-up or a 
third follow-up is required to detect significant increasing alterations to confirm 
compensatory mechanisms. These longitudinal results are preliminary and form part 
of an on-going study within TransEuro whereby completion of the second follow-up 
and initiation of a third follow-up scan is planned within the next 12 months in more 
than 40 PD patients. It is expected that increasing the sample size as well as the period 
of time between the baseline scan will be critical in revealing robust compensatory 
mechanisms serving as a motor reserve capacity to cope with disease progression and 
increasing symptomatology.  
 
4. Nigral diffusion indices in PD 
Conclusive evidence supporting the use of diffusion measures as a biomarker for PD 
is strongly awaited to aid premotor diagnosis and perhaps the development of disease-
modifying therapies. However, the relationship between diffusion parameter 
alteration and clinical symptomatology such as motor dysfunction is not clear. There 
are some evidence of using diffusion measures to quantify disease processes in PD, 
although there are debates in the literature regarding the reliability of diffusion 
measures such as FA and MD at capturing the microstructural changes of motor 
pathways. The study presented in Chapter 5 is the first to follow a group of PD 
patients over time to investigate nigro-striatal changes in FA and MD in PD. It is 
concluded from this study that measures of nigral MD may be a better predictor of 
diffusion related alterations due to disease processes than nigral FA or striatal 
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diffusion indices. It is appreciated that due to the small sample size and perhaps less 
than optimal acquisition sequence, these data should be considered as preliminary and 
further studies should seek to improve sample size and scanning protocols.  
 
5. Limitations of thesis studies and building on the current work 
5.1 Limitations of current studies 
The current studies have provided information regarding the alteration of motor brain 
networks in PD. In particular, the potential compensatory reserve capacity of the PD 
brain to cope with difficulties performing movements due to disease processes has 
been highlighted. However, these studies have been limited by a number of factors: 
-­‐ Sample size: Although sample sizes in Chapter 3 were reasonable, future 
studies should aim to increase them for power and sensitivity at cross-
sectional level. Similarly, despite increased sensitivity due to a longitudinal 
design, fMRI results, in particular robust identification of compensatory 
mechanisms in Chapter 4 could potentially be enhanced and with a larger 
sample size. Chapter 5, certainly requires larger sample sizes to delineate 
diffusion property alterations over time.  
-­‐ Comparable samples: In order to fully investigate structure-function 
relationships in a true multimodal fashion, comparable sample sizes for both 
modalities are required. In this thesis, diffusion data were available for fewer 
patients due to compromised data as discussed below. In order to increase 
power for multimodal fMRI-DTI comparisons, future follow-up data as part of 
the on-going TransEuro study will provide a larger sample size enabling these 
analyses. 
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-­‐ DTI sequence protocol: Unfortunately, only a single b0 was collected during 
data acquisition. B0 images enable division of baseline signal of tissues and 
remove sources of signal variance, such as movement.  Due to the nature of 
PD, movements during the DTI scan lead to a loss of signal in frontal brain 
areas. As such, a large proportion of the data were compromised and deemed 
invalid for analysis purposes. As previously mentioned, further data will be 
acquired with the aim of increasing the useable data set.  
 
5.2 Considerations for building on the current studies 
Based on the above limitations, there are several improvements that could be made to 
future studies intending to build on the work presented here.  
First and foremost, as with all neuroimaging studies, sample sizes should be 
increased. This is particularly pertinent for the cross-sectional fMRI motor study and 
DTI study. The former has a reasonable number of subjects per group (n=16) 
however, due to the cross-sectional design, multiple comparisons across groups 
consisting of a larger number of subjects per group would increase power and lead to 
more reliable results. Furthermore, the ability to then confirm results found with a 
longitudinal design (such as that conducted in Chapter 4) would be increased. The 
current DTI study (Chapter 5) was a longitudinal design, which in itself increases 
power however, the sample size of n=18 which could be considered a small study, 
increases the possibility of reported averages, standard deviations and effect sizes 
being quite variable and affecting results. Secondly, future studies should include not 
just ore PD patients, but patients with a wider range of disease severity. The current 
studies focused on relatively early PD thus later disease processes could not be 
considered.  
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Future studies should also consider including additional and alternative methods when 
for functional connectivity analyses. Here, seed ROI correlation analyses were used 
and although this was justified due to the strong a priori hypotheses, this approach 
can be prone to detecting spurious correlations when sufficient de-noising is not 
implemented. A relatively new method of de-noising which models the motion, 
physiological (if data collected at the time) and scanner artefacts can be regressed out 
leaving behind data which is a more ‘true’ representation of BOLD signal (FMRIBs 
ICA-based Xnoiseifier; FIX). Applying such a tool on the current dataset would have 
produced cleaner and more reliable results. However, FIX is predominately designed 
to deal with rs-fMRI data and although theoretically can be applied to task data, the 
group have not announced any testing or documentation of using this method for task 
data. Another approach that could be considered in future studies is that of effective 
connectivity. Ultimately the aim of the functional connectivity analyses is to make 
claims regarding causality. Several approaches maybe taken to achieve this: structural 
equation modeling and dynamic causal modeling for example. However, there are 
challenges to casual inference in fMRI data such as the size of the model space. To 
complete an exhaustive search of the entire model space for all possible relationships 
between regions, is impossible with modern computers and as such, a portion of the 
model space can be interrogated only.  
Future studies should consider the influence of medication more closely in particular 
when considering longitudinal studies. It is logical that as disease severity increases 
with time, so does LED in patients. How this increase of mediation interacts with the 
measured BOLD signal has not been investigated in the current studies and should be 
considered in future.  
	   137	  
The current studies detected increases in activity within many motor related regions, 
which are also part of the attention network. Due to PD patients experiencing 
increasing difficulty of motor performance, it may be possible that increases are due 
to an increased load on the attention network not only due to a motor reserve capacity. 
This aspect was unexplored in the current studies but future studies could easily 
include an attention cue during the motor task to model this aspect into the analysis 
design.   
 
6. Implications for future research 
Multimodal imaging studies 
Unimodal imaging studies are still the predominant method to assess brain changes in 
PD. However, advances in neuroimaging techniques, which permit investigation of 
the interplay between anatomical, functional and physiological alterations in the 
diseased brain, and should lead to greater understanding of structure-function 
relationships. To date, no study has been undertaken to combine multimodal 
technique to investigate motor control in PD. The closest has been conducted by Wu 
et al., (Wu et al. 2012) who used task-based fMRI to identify ROIs for investigation 
of the resting network.  Correlational analyses are an important element of 
multimodal studies with distinction between pure correlations and predictive 
correlations such as multivariate regression, which are restricted to linear observations 
and may miss important information regarding non-linear connectivity. Structural 
equation modelling also assumes the interactions are linear and, furthermore, 
instantaneous in the sense that structural equation models are not time-series models. 
Dynamic causal modeling is an alternative to these approaches by accommodating the 
nonlinear and dynamic aspects of neuronal interactions. Causal or explanatory 
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variables that comprise the conventional design matrix become the inputs and the 
parameters become measures of effective connectivity. As such, non-linear interaction 
between modalities could be included in the design making integration of modalities 
within a study more comparable. Finally, there has been an increased interest in 
dynamic bivariate correlations in quantifying possible dynamic changes in FC during 
fMRI experiments, as it is thought that this may provide insight into the fundamental 
workings of brain networks. In this work we focus on the specific problem of 
estimating the dynamic behaviour of pair-wise correlations between time courses 
extracted from two different regions of the brain. 
It is clear that much work remains to be done in order to characterize the promising 
multimodal approaches. It is helpful to consider unimodal results in comparison to 
multimodal approaches. In this thesis, a multimodal approach has been attempted, 
although results of individual modalities have not been directly integrated, i.e. with 
dynamic causal modeling. A number of study limitations did not allow this within the 
realm of this thesis and was discussed earlier. Although, this thesis presents for the 
first time three concurrent imaging techniques with the same endpoint; alteration of 
brain motor networks due to disease processes. 
 
Characterisation of a prodromal PD 
PD is a progressive neurodegenerative disease that is characterized by DA depletion. 
By symptom emergence, invariably approximately 70% of nigral DA neurons will 
have been lost (Fearnley & Lees 1991). Thus, it is supposed that the loss of these 
neurons begins perhaps up to 10 years prior to symptom onset. As such, interventions 
within a prodromal stage of PD may well lead to progression slowing as well as 
prevention of cardinal symptoms. Using neuroimaging to define biomarkers is 
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paramount to enabling early PD diagnosis. By fully elucidating the natural course of 
motor network alteration in PD, on could potentially use a top-down approach to 
inform preliminary stages of network alteration in a prodromal stage of PD. For 
instance, this thesis has attempted to comprehensively assess the motor network and 
should form a basis for future studies to elucidate the staging of motor network 
dysfunction in both the active and resting brain state as well as from a regional and 
connectivity point of view.  Here, it is demonstrated that in general, inter-motor 
cortices connectivity significantly declines during earlier disease burdens with striato-
cortico connectivity appearing the be the first regions to indicate compensatory 
changes.  
 
Implementation of ‘well-timed’ therapy 
A key aspect of identifying a prodromal PD and for defining periods during 
established disease progression whereby compensatory reserve processes are 
initiating, serve to inform the existence of ‘windows of opportunities’ for future 
targeted therapies. This may well take the form of timing the introduction or dosage 
increase of DA-ergic therapies to derive the most benefit or inform new neuro-
protective therapy development.   
 
End-point chatracterisation in clinical trials 
Using neuroimaging techniques to form part of end-point definition in clinical trials 
has been a mainstay for restorative therapies. Typically, invasive 18F-Dopa PET 
imaging has been implemented as the gold standard for measuring DA-ergic function 
and restoration following surgical interventions. However, to define functional 
alterations using fMRI will enable cheaper, non-invasive end-point methodology.  
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Non-invasive MRI techniques have the potential to assess restoration of brain activity 
during movement and of the structural and functional connectivity changes. As 
always, definition and characterisation of the motor networks change sin PD must be 
established prior to the sole use of MRI techniques as clinical trial end-points. 
However, combination of PET and MRI techniques should lead to better scheduling, 
monitoring, and modification of clinical outcomes.   
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